The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterised by widespread areas of focal demyelination. Its aetiology and pathogenesis remain unclear despite substantial insights gained through studies of animal models, most notably experimental autoimmune e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple Sclerosis International Jg. 2014; H. 2014; S. 56 - 72
Hauptverfasser: Duffy, Samuel S., Moalem-Taylor, Gila, Lees, Justin G.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Cairo, Egypt Hindawi Limiteds 01.01.2014
Hindawi Publishing Corporation
Hindawi Limited
John Wiley & Sons, Inc
Schlagworte:
Analysis
Antigens
Autoimmune diseases
Cytokines
Development and progression
Encephalomyelitis
Genetic aspects
Immune system
Lymphocytes
Multiple sclerosis
Nervous system
Neurodegeneration
Paralysis
Pathogenesis
Physiological aspects
Proteins
Review
Tumor necrosis factor-TNF
Australia
ISSN:2090-2654, 2090-2662
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterised by widespread areas of focal demyelination. Its aetiology and pathogenesis remain unclear despite substantial insights gained through studies of animal models, most notably experimental autoimmune encephalomyelitis (EAE). MS is widely believed to be immune-mediated and pathologically attributable to myelin-specific autoreactive CD4+ T cells. In recent years, MS research has expanded beyond its focus on CD4+ T cells to recognise the contributions of multiple immune and glial cell types to the development, progression, and amelioration of the disease. This review summarises evidence of T and B lymphocyte, natural killer cell, macrophage/microglial, astrocytic, and oligodendroglial involvement in both EAE and MS and the intercommunication and influence of each cell subset in the inflammatory process. Despite important advances in the understanding of the involvement of these cell types in MS, many questions still remain regarding the various subsets within each cell population and their exact contribution to different stages of the disease.
AbstractList Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterised by widespread areas of focal demyelination. Its aetiology and pathogenesis remain unclear despite substantial insights gained through studies of animal models, most notably experimental autoimmune encephalomyelitis (EAE). MS is widely believed to be immune-mediated and pathologically attributable to myelin-specific autoreactive CD4+ T cells. In recent years, MS research has expanded beyond its focus on CD4+ T cells to recognise the contributions of multiple immune and glial cell types to the development, progression, and amelioration of the disease. This review summarises evidence of T and B lymphocyte, natural killer cell, macrophage/microglial, astrocytic, and oligodendroglial involvement in both EAE and MS and the intercommunication and influence of each cell subset in the inflammatory process. Despite important advances in the understanding of the involvement of these cell types in MS, many questions still remain regarding the various subsets within each cell population and their exact contribution to different stages of the disease.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterised by widespread areas of focal demyelination. Its aetiology and pathogenesis remain unclear despite substantial insights gained through studies of animal models, most notably experimental autoimmune encephalomyelitis (EAE). MS is widely believed to be immune-mediated and pathologically attributable to myelin-specific autoreactive CD4+ T cells. In recent years, MS research has expanded beyond its focus on CD4+ T cells to recognise the contributions of multiple immune and glial cell types to the development, progression, and amelioration of the disease. This review summarises evidence of T and B lymphocyte, natural killer cell, macrophage/microglial, astrocytic, and oligodendroglial involvement in both EAE and MS and the intercommunication and influence of each cell subset in the inflammatory process. Despite important advances in the understanding of the involvement of these cell types in MS, many questions still remain regarding the various subsets within each cell population and their exact contribution to different stages of the disease.Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterised by widespread areas of focal demyelination. Its aetiology and pathogenesis remain unclear despite substantial insights gained through studies of animal models, most notably experimental autoimmune encephalomyelitis (EAE). MS is widely believed to be immune-mediated and pathologically attributable to myelin-specific autoreactive CD4+ T cells. In recent years, MS research has expanded beyond its focus on CD4+ T cells to recognise the contributions of multiple immune and glial cell types to the development, progression, and amelioration of the disease. This review summarises evidence of T and B lymphocyte, natural killer cell, macrophage/microglial, astrocytic, and oligodendroglial involvement in both EAE and MS and the intercommunication and influence of each cell subset in the inflammatory process. Despite important advances in the understanding of the involvement of these cell types in MS, many questions still remain regarding the various subsets within each cell population and their exact contribution to different stages of the disease.
Audience Academic
Author Duffy, Samuel S.
Lees, Justin G.
Moalem-Taylor, Gila
AuthorAffiliation School of Medical Science, The University of New South Wales, Wallace Wurth Building East, Level 3, Room 327, Sydney, NSW 2052, Australia
AuthorAffiliation_xml – name: School of Medical Science, The University of New South Wales, Wallace Wurth Building East, Level 3, Room 327, Sydney, NSW 2052, Australia
Author_xml – sequence: 1
  fullname: Duffy, Samuel S.
– sequence: 2
  fullname: Moalem-Taylor, Gila
– sequence: 3
  fullname: Lees, Justin G.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25374694$$D View this record in MEDLINE/PubMed
BookMark eNqFktFv0zAQxiM0xEbZE-8oEhJCoG62EzvJC1JVlTE0BBLl2XKdy-LJsUOcAP3vuTalaycQ8UMS-3ffne--p9GJ8w6i6DklF5RyfskITS9ZzlnKH0VnjBRkyoRgJ_tvnp5G5yHcEXw4YVmePIlOGU-yVBTpWRSWNcRz7_rOrIbeeBf7Kr5umsFBrFwZX1mjbDwHa-PluoUQGxcvfrXQmQZcj0ezofdm5BdOQ1sr65s1WNObsFX4NNjetBbir9pC54MJz6LHlbIBznfvSfTt_WI5_zC9-Xx1PZ_dTJVgeT_lvOC0ZFWhNeQUVrkoRU6JEFWuK81SCoJpBiqjqhBJCQXLCedVqStIIclUMonejbrtsGqg1Fhwp6xssXbVraVXRh6fOFPLW_9DpozShHIUeL0T6Pz3AUIvGxM09kI58EOQVDBGBI4hQ_TlA_TOD53D60mWkkzwPBfpPXWrLEjjKo959UZUzjBpQQouKFIXf6FwldAYjfOvDO4fBbw6CKhB2b4O3m7nGY7BF4cd2bfijx8QeDsCGicVOqj2CCVyYzi5MZwcDYc0fUBr06tNVizY2H_EvBljauNK9dP8J8GuXkAEKnUAp4Lj1CfRxxFQpkPH3Tf9C8pwyighlG4lKZP7LUKT4x8uZMaS3xqkAHY
CitedBy_id crossref_primary_10_1155_2022_3201644
crossref_primary_10_1002_jnr_24073
crossref_primary_10_1111_jnc_13714
crossref_primary_10_1111_ejn_14887
crossref_primary_10_3389_fnins_2015_00198
crossref_primary_10_3389_fimmu_2015_00541
crossref_primary_10_1007_s12035_021_02552_1
crossref_primary_10_1016_j_jneuroim_2020_577281
crossref_primary_10_1038_s41598_021_86191_5
crossref_primary_10_1007_s10753_015_0230_1
crossref_primary_10_3389_fimmu_2018_02336
crossref_primary_10_3389_fneur_2020_580951
crossref_primary_10_1007_s11064_018_2509_8
crossref_primary_10_1016_j_heliyon_2021_e07151
crossref_primary_10_7717_peerj_1600
crossref_primary_10_3389_fimmu_2016_00369
crossref_primary_10_1002_glia_23940
crossref_primary_10_1007_s10616_015_9942_1
crossref_primary_10_3389_fimmu_2020_566225
crossref_primary_10_4103_1673_5374_300975
crossref_primary_10_1007_s12035_023_03593_4
crossref_primary_10_1002_jnr_24224
crossref_primary_10_1007_s12035_017_0627_y
crossref_primary_10_1186_s12974_019_1622_1
crossref_primary_10_1186_s12987_019_0138_5
crossref_primary_10_3389_fimmu_2021_533423
crossref_primary_10_1007_s10753_018_0748_0
crossref_primary_10_1515_revneuro_2021_0062
crossref_primary_10_1080_23328940_2018_1475831
crossref_primary_10_3389_fimmu_2015_00539
crossref_primary_10_1007_s12035_020_01891_9
crossref_primary_10_1155_2024_5383099
crossref_primary_10_1093_jmicro_dfv349
crossref_primary_10_3389_fnagi_2020_544235
crossref_primary_10_3389_fnagi_2025_1570428
Cites_doi 10.3389/fncel.2013.00034
10.1084/jem.20111675
10.1038/nm.2266
10.1002/ana.22339
10.3727/096368911X637443
10.1038/nature01355
10.1172/JCI36030
10.1002/ana.21800
10.1073/pnas.1300313110
10.4049/jimmunol.164.1.183
10.1016/j.bbi.2013.07.176
10.4049/jimmunol.151.4.2132
10.1177/1352458510379243
10.1016/j.jaut.2013.06.004
10.1093/brain/awp070
10.1002/ana.22081
10.1073/pnas.92.24.11066
10.1189/jlb.0710409
10.1016/j.brainres.2008.05.004
10.2353/ajpath.2008.070690
10.1002/eji.200526065
10.1002/glia.21054
10.1016/j.ajpath.2013.04.016
10.4049/jimmunol.175.11.7103
10.1212/WNL.53.3.457
10.4049/jimmunol.175.5.3025
10.1016/j.clim.2011.09.006
10.1371/journal.pone.0026921
10.1038/nature06306
10.1371/journal.pone.0017103
10.4049/jimmunol.0802954
10.3109/08916934.2012.665523
10.1111/cei.12209
10.1016/j.bbi.2010.10.001
10.1097/01720610-201208000-00005
10.1016/0092-8674(93)90074-Z
10.1002/eji.1830270822
10.1016/S1474-4422(08)70173-X
10.1126/science.256.5060.1210
10.1016/j.jneuroim.2011.09.013
10.4049/jimmunol.0901906
10.1186/1742-2094-10-94
10.1096/fj.05-5465com
10.1002/eji.200737810
10.4049/jimmunol.175.9.5875
10.1182/blood-2003-11-4025
10.4049/jimmunol.180.7.4495
10.4049/jimmunol.0902739
10.1038/ni1507
10.1371/journal.pone.0039625
10.1523/JNEUROSCI.1514-09.2009
10.4049/jimmunol.166.12.7579
10.1016/j.ajpath.2013.10.009
10.1038/nn.2887
10.1084/jem.185.12.2177
10.1016/j.jneuroim.2011.05.005
10.3109/00207459709000638
10.1002/eji.200425660
10.1084/jem.20031579
10.1016/j.cyto.2008.08.007
10.1523/JNEUROSCI.1028-11.2011
10.1016/j.jneuroim.2013.04.014
10.1016/j.jneuroim.2005.02.011
10.1191/135245801681137960
10.4049/jimmunol.1103354
10.4049/jimmunol.181.12.8278
10.1002/stem.1218
10.1006/cimm.1998.1365
10.1371/journal.pone.0042088
10.1038/356063a0
10.1001/archneurol.2009.50
10.4049/jimmunol.157.8.3223
10.1016/j.neuroscience.2005.04.026
10.4049/jimmunol.141.7.2407
10.1038/39614
10.1084/jem.58.1.39
10.4049/jimmunol.160.10.4822
10.1002/eji.201444612
10.4049/jimmunol.1100421
10.1016/j.jneuroim.2012.08.009
10.1016/j.molimm.2010.03.014
10.1172/JCI119396
10.1016/0165-5728(92)90042-J
10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A
10.1084/jem.187.9.1517
10.1016/j.jneuroim.2012.03.020
10.1016/j.jneuroim.2009.05.017
10.4049/jimmunol.156.1.5
10.1007/s00401-014-1260-8
10.1084/jem.20070634
10.1002/eji.201242679
10.1084/jem.184.1.19
10.4049/jimmunol.140.5.1506
10.1038/ni.1952
10.1002/glia.20199
10.1016/0165-5728(93)90241-P
10.1038/nm1402
10.1038/nn.3505
10.1016/j.jneuroim.2013.10.004
10.3121/cmr.1.1.57
10.1084/jem.194.5.669
10.1371/journal.pmed.1000113
10.1016/0167-5699(96)80606-2
10.1016/j.immuni.2010.03.004
10.2119/molmed.2011.00077
10.1038/nn.3168
10.1073/pnas.0308689100
10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
10.1002/glia.22634
10.1038/ni.1716
10.1006/mcne.1998.0725
10.1093/intimm/dxq463
10.1084/jem.184.6.2271
10.1038/nature12979
10.1016/j.neulet.2013.08.062
10.1084/jem.186.9.1585
10.4049/jimmunol.179.2.958
10.1073/pnas.0601335103
10.1016/j.ejca.2006.01.003
10.1002/ana.20913
10.1038/ni.2027
10.1016/j.bbi.2008.09.004
10.1016/S1474-4422(02)00102-3
10.1016/S0165-5728(98)00083-6
10.1186/1471-2172-8-10
10.1084/jem.189.6.1005
10.1038/nri3071
10.4049/jimmunol.0802221
10.3389/fimmu.2014.00087
10.1089/10430349850019445
10.4049/jimmunol.177.1.566
10.1016/S1074-7613(00)80186-7
10.1002/ana.22054
10.1126/science.3131876
10.1002/eji.1830250723
10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A
10.1002/ana.21652
10.1016/0165-5728(93)90240-Y
10.4049/jimmunol.154.9.4309
10.1126/science.1227901
10.1212/WNL.37.7.1097
10.4049/jimmunol.174.10.5950
10.1016/j.cellimm.2005.11.002
10.1016/0165-5728(94)00139-F
10.1523/JNEUROSCI.20-14-05283.2000
10.1007/s11910-009-0060-3
10.1038/nri2190
10.1073/pnas.92.26.12041
10.1038/nm.3485
10.1080/08916930400001859
10.1038/nm1564
10.1016/S0165-5728(98)00053-8
10.1371/journal.pone.0054841
10.1038/nature03725
10.1002/glia.22616
10.1371/journal.pone.0017988
10.1016/j.bbi.2007.11.010
10.1084/jem.192.3.393
10.1038/sj.gt.3301357
10.1523/JNEUROSCI.1137-14
10.1073/pnas.97.7.3412
10.4061/2011/164608
10.1084/jem.186.10.1677
10.1093/intimm/13.3.257
10.1371/journal.pone.0021386
10.1007/s00401-014-1267-1
10.1056/NEJMoa1100648
10.1038/82717
10.1016/j.jneuroim.2012.02.015
10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T
10.1038/nrn3275
10.1084/jem.20041257
10.1111/j.1365-2249.2005.02934.x
10.1093/brain/awp289
10.1016/S0165-5728(99)00133-2
10.1056/NEJM200009283431307
10.1002/glia.21088
10.3390/ijms15021700
10.1016/j.bbi.2010.01.014
10.1126/science.256.5060.1213
10.1212/WNL.46.4.907
10.1038/ni833
10.1371/journal.pone.0060862
10.1523/JNEUROSCI.3411-10.2010
10.1001/archneur.56.9.1079
10.1038/nm0198-078
10.1002/eji.1830110307
10.1093/intimm/9.5.799
10.1016/j.nbd.2011.05.021
10.1084/jem.184.5.1609
10.4049/jimmunol.1300822
10.1002/eji.201040489
10.1016/S0165-5728(98)00014-9
10.1038/nm1651
10.1172/JCI35997
10.1111/j.1365-2567.2010.03261.x
10.1172/JCI63681
10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T
10.4049/jimmunol.161.7.3299
10.1002/jnr.20488
10.1016/j.bbi.2011.05.003
10.4049/jimmunol.175.11.7202
10.1212/WNL.0000000000000560
10.1056/NEJMoa0802670
ContentType Journal Article
Copyright Copyright © 2014 Samuel S. Duffy et al.
COPYRIGHT 2014 Hindawi Limited
Copyright © 2014 Samuel S. Duffy et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2014 Samuel S. Duffy et al. 2014
Copyright_xml – notice: Copyright © 2014 Samuel S. Duffy et al.
– notice: COPYRIGHT 2014 Hindawi Limited
– notice: Copyright © 2014 Samuel S. Duffy et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2014 Samuel S. Duffy et al. 2014
DBID 188
ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1155/2014/285245
DatabaseName Airiti Library
الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef


Publicly Available Content Database
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2090-2662
Editor Bruck, Wolfgang
Editor_xml – sequence: 1
  givenname: Wolfgang
  surname: Bruck
  fullname: Bruck, Wolfgang
EndPage 72
ExternalDocumentID PMC4211315
A421909561
25374694
10_1155_2014_285245
1046596
P20151210011_201412_201512100013_201512100013_56_72
Genre Journal Article
Review
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GroupedDBID ---
188
24P
2UF
4.4
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJEY
ABDBF
ABUWG
ADBBV
ADRAZ
AFKRA
AFPKN
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
CCPQU
CEFSP
CNMHZ
EBD
EBS
EJD
ESX
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M48
M~E
OK1
PGMZT
PIMPY
RHX
RNS
RPM
TUS
UKHRP
UZ5
0R~
AAMMB
ACCMX
ACUHS
ADJCN
AEFGJ
AGXDD
AHFXO
AIDQK
AIDYY
IL9
PHGZM
PHGZT
PUEGO
RHU
RHW
AAYXX
AFFHD
ALUQN
CITATION
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-a628t-55951d2f9cce81eb86d681066f8cfc241e62c2ea71a963de928055fdcfe4e37a3
IEDL.DBID RHX
ISICitedReferencesCount 95
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000215745600007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2090-2654
IngestDate Tue Nov 04 02:05:49 EST 2025
Wed Oct 01 13:22:05 EDT 2025
Tue Oct 07 07:08:04 EDT 2025
Tue Nov 11 09:58:25 EST 2025
Tue Nov 04 17:57:20 EST 2025
Thu May 22 20:56:42 EDT 2025
Wed Feb 19 01:52:48 EST 2025
Sat Nov 29 02:54:09 EST 2025
Tue Nov 18 22:32:47 EST 2025
Sun Jun 02 18:52:52 EDT 2024
Thu Sep 25 15:12:31 EDT 2025
Tue Oct 01 22:51:11 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2014
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a628t-55951d2f9cce81eb86d681066f8cfc241e62c2ea71a963de928055fdcfe4e37a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Academic Editor: Wolfgang Bruck
ORCID 0000-0003-3828-9527
OpenAccessLink https://dx.doi.org/10.1155/2014/285245
PMID 25374694
PQID 2407658864
PQPubID 4727247
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4211315
proquest_miscellaneous_1622061557
proquest_journals_2407658864
gale_infotracmisc_A421909561
gale_infotracacademiconefile_A421909561
gale_healthsolutions_A421909561
pubmed_primary_25374694
crossref_primary_10_1155_2014_285245
crossref_citationtrail_10_1155_2014_285245
hindawi_primary_10_1155_2014_285245
emarefa_primary_1046596
airiti_journals_P20151210011_201412_201512100013_201512100013_56_72
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: Egypt
– name: New York
PublicationTitle Multiple Sclerosis International
PublicationTitleAlternate Mult Scler Int
PublicationYear 2014
Publisher Hindawi Limiteds
Hindawi Publishing Corporation
Hindawi Limited
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi Limiteds
– name: Hindawi Publishing Corporation
– name: Hindawi Limited
– name: John Wiley & Sons, Inc
References (61) 2014; 15
(34) 2005; 175
(126) 2000; 12
(40) 1999; 53
(127) 2012; 45
(121) 2011; 6
(14) 1993; 72
(64) 2009; 23
(130) 2012; 246
(84) 2009; 132, part 12
(191) 2013; 43
(201) 2011; 31
(103) 2013; 123
(167) 2013; 554
(59) 2001; 8
(131) 2000; 1
(60) 1998; 9
(72) 2009; 10
(5) 2000; 343
(96) 2013; 191
(196) 2002; 1
(41) 1987; 37
(12) 2006; 60
(139) 2012; 188
(86) 2007; 13
(11) 2007; 7
(45) 1996; 156
(3) 2012; 25
(71) 2005; 237
(85) 2009; 65
(28) 1995; 92
(192) 2013; 34
(205) 2010; 58
(151) 2000; 20
(55) 2005; 175
(134) 2008; 118
(144) 1998; 28
(181) 2005; 142
(159) 2009; 66
(18) 2012; 13
(23) 1992; 356
(81) 2006; 177
(148) 2006; 20
(13) 1995; 25
(120) 2011; 240-241
(93) 2013; 260
(199) 2014; 184
(42) 1998; 12
(78) 2005; 201
(39) 2014; 175
(165) 2014; 128
(209) 2013; 183
(154) 2011; 23
(29) 1997; 27
(52) 2001; 7
(70) 2002; 13
(17) 2001; 13
(50) 2004; 103
(90) 2001; 166
(76) 2010; 40
(145) 2011; 69
(177) 2011; 89
(48) 1992; 36
(128) 1999; 101
(67) 2000; 11
(27) 2008; 22
(210) 2013; 16
(123) 1996; 184
(109) 2000; 164
(37) 1997; 186
(162) 2011; 14
(7) 2013; 83
(22) 1981; 11
(56) 1997; 9
(57) 1998; 87
(189) 2005; 51
(115) 2010; 11
(51) 2008; 44
(168) 1998; 22
(15) 2000; 97
(195) 1993; 151
(114) 2010; 184
(170) 2012; 188
(153) 1998; 86
(156) 2011; 141
(98) 2000; 192
(176) 2011; 11
(197) 1995; 92
(32) 1999; 29
(21) 2009; 9
(185) 2010; 32
(124) 2005; 174
(169) 1995; 154
(79) 2009; 183
(2) 2011; 17
(49) 2014
(110) 1988; 240
(146) 1997; 186
(38) 1999; 29
(33) 1995; 56
(105) 2005; 435
(88) 1992; 256
(129) 2012; 247
(152) 2013; 254
(198) 2011; 2011
(172) 2007; 8, article 10
(35) 1997; 185
(182) 2011; 17
(9) 1999; 56
(80) 2009; 182
(100) 1997; 99
(73) 2007; 8
(179) 2006; 42
(69) 1998; 87
(190) 2011; 25
(138) 2010; 68
(125) 2014; 20
(180) 2013; 8
(75) 2011; 25
(62) 1998; 188
(175) 2013; 339
(25) 2009; 132
(140) 2011; 6
(10) 1933; 58
(65) 1999; 189
(106) 2005; 175
(200) 2014; 62
(113) 2007; 37
(122) 2006; 12
(44) 2010; 130
(43) 2010; 24
(118) 1996; 184
(171) 2009; 6
(97) 2004; 101
(74) 2003; 421
(112) 2007; 450
(143) 2007; 204
(46) 1996; 157
(188) 2014; 62
(149) 2008; 180
(19) 2009; 66
(119) 2011; 6
(83) 2008; 7
(163) 2005; 81
(20) 2012; 15
(157) 2011; 236
(174) 2011; 17
(193) 2011; 59
(160) 2012; 7
(164) 2013; 7
(89) 1992; 256
(91) 2001; 194
(111) 1997; 389
(155) 2013; 265
(150) 2013; 8
(54) 2010; 47
(77) 2011; 12
(87) 2013; 45
(183) 2014; 34
(82) 2009; 119
(187) 2009; 182
(137) 2008; 181
(202) 2006; 129, part 12
(102) 2013; 10
(158) 2006; 103
(94) 2013; 171
(26) 2010; 68
(53) 1996; 17
(133) 1996; 184
(116) 2004; 199
(136) 2014; 507
(47) 1988; 140
(207) 2012; 21
(58) 1998; 160
(147) 2005; 163
(24) 1993; 46
(31) 2004; 37
(95) 2009; 213
(117) 2005; 35
(36) 1998; 4
(8) 1996; 46
(142) 2014; 5
(186) 2009; 29
(66) 1993; 46
(108) 2007; 179
(178) 1988; 141
(1) 2003; 1
(4) 2012; 37
(204) 2014; 128
(203) 2010; 30
(206) 2012; 30
(92) 2005; 35
(101) 2008; 359
(173) 2013; 110
(16) 2005; 134
(184) 2011; 6
(141) 2012; 209
(104) 2008; 172
(68) 1997; 90
(194) 2012; 7
(6) 2001; 71
(132) 2005; 175
(99) 2011; 365
(30) 1998; 187
(135) 2002; 3
(161) 2000; 47
(107) 2007; 13
(208) 2011; 43
(166) 2008; 1219
(63) 1998; 161
(64) 1998; 161
110
111
112
113
114
115
116
117
118
119
(48) 1988; 140
11
12
13
14
15
16
(71) 2002; 13
17
18
19
120
121
1
122
2
123
3
124
125
5
126
127
7
128
8
129
9
20
21
22
23
24
25
26
27
28
29
(196) 1993; 151
130
131
132
133
134
135
136
137
138
139
(162) 2000; 47
30
(59) 1998; 160
31
32
33
34
35
36
37
38
39
140
141
142
143
144
(170) 1995; 154
146
147
(158) 2011; 236
148
149
(68) 2000; 11
42
43
44
45
49
150
151
153
154
155
156
157
159
50
51
52
53
54
55
56
57
58
(179) 1988; 141
160
161
163
164
165
166
167
168
60
61
62
63
65
66
67
69
171
172
173
175
176
177
178
70
72
73
74
75
76
77
78
(41) 1999; 53
79
180
(174) 2013; 110
181
182
(95) 2013; 171
183
(169) 1998; 22
184
185
186
187
188
189
80
81
82
83
84
85
86
87
88
89
190
191
192
193
194
195
197
198
199
90
91
92
93
94
96
97
98
99
(46) 1996; 156
(47) 1996; 157
200
(152) 2000; 20
201
202
204
205
206
207
208
209
(145) 1998; 28
210
211
100
101
102
103
104
105
106
107
108
109
(203) 2006; 129, part 12
23871638 - J Autoimmun. 2013 Sep;45:68-79
14983026 - Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2428-33
19364933 - Arch Neurol. 2009 Apr;66(4):483-9
18033300 - Nature. 2007 Nov 22;450(7169):566-9
18207698 - Brain Behav Immun. 2008 May;22(4):421-30
18793860 - Cytokine. 2008 Oct;44(1):22-5
20406305 - Immunology. 2010 Aug;130(4):572-88
15959904 - J Neurosci Res. 2005 Aug 1;81(3):374-89
16116190 - J Immunol. 2005 Sep 1;175(5):3025-32
21679768 - Neurobiol Dis. 2011 Sep;43(3):678-89
3126227 - J Immunol. 1988 Mar 1;140(5):1506-10
17874423 - Eur J Immunol. 2007 Nov;37(11):3021-9
9352427 - Int J Neurosci. 1997 Aug;90(3-4):187-202
18946064 - N Engl J Med. 2008 Oct 23;359(17):1786-801
16237080 - J Immunol. 2005 Nov 1;175(9):5875-84
23011975 - Eur J Immunol. 2013 Jan;43(1):115-24
14976054 - Blood. 2004 Jun 1;103(11):4222-31
23995070 - Nat Neurosci. 2013 Oct;16(10):1401-8
17712344 - Nat Immunol. 2007 Sep;8(9):913-9
21437244 - PLoS One. 2011 Mar 18;6(3):e17988
9295034 - Eur J Immunol. 1997 Aug;27(8):1973-81
24021808 - Neurosci Lett. 2013 Oct 25;554:146-50
18538310 - Brain Res. 2008 Jul 11;1219:116-26
15621573 - Autoimmunity. 2004 Sep-Nov;37(6-7):465-71
21984069 - Nat Rev Immunol. 2011 Oct 10;11(11):738-49
15067033 - J Exp Med. 2004 Apr 5;199(7):971-9
23664330 - J Neuroimmunol. 2013 Jul 15;260(1-2):17-27
22531276 - J Neuroimmunol. 2012 Jun 15;247(1-2):86-94
21131957 - Nat Med. 2011 Jan;17(1):64-70
19636355 - PLoS Med. 2009 Jul;6(7):e1000113
16785554 - J Immunol. 2006 Jul 1;177(1):566-73
20540117 - Eur J Immunol. 2010 Aug;40(8):2340-8
19475668 - Ann Neurol. 2009 May;65(5):499-509
8102159 - J Immunol. 1993 Aug 15;151(4):2132-41
11390514 - J Immunol. 2001 Jun 15;166(12):7579-87
11724442 - Mult Scler. 2001 Oct;7(5):277-84
11222494 - Int Immunol. 2001 Mar;13(3):257-64
9565643 - J Exp Med. 1998 May 4;187(9):1517-28
17617587 - J Immunol. 2007 Jul 15;179(2):958-66
20737479 - Glia. 2010 Nov 15;58(15):1847-57
19305396 - Nat Immunol. 2009 May;10(5):514-23
21620951 - Brain Behav Immun. 2011 Nov;25(8):1554-68
24463292 - Int J Mol Sci. 2014 Jan 23;15(2):1700-18
22469520 - Cell Transplant. 2012;21(9):1883-97
7722289 - J Immunol. 1995 May 1;154(9):4309-21
1375398 - Science. 1992 May 22;256(5060):1213-5
23418431 - PLoS One. 2013;8(2):e54841
9759845 - J Immunol. 1998 Oct 1;161(7):3299-306
16520032 - Eur J Cancer. 2006 Apr;42(6):717-27
20035511 - Ann Neurol. 2009 Dec;66(6):739-53
22928273 - JAAPA. 2012 Aug;25(8):24-9
24357067 - Glia. 2014 Mar;62(3):452-67
20641064 - Ann Neurol. 2010 Sep;68(3):369-83
21046558 - Glia. 2011 Jan;59(1):166-76
10934227 - J Exp Med. 2000 Aug 7;192(3):393-404
20138983 - Brain Behav Immun. 2010 May;24(4):641-51
22073221 - PLoS One. 2011;6(11):e26921
15593305 - Eur J Immunol. 2005 Jan;35(1):76-85
9184926 - Int Immunol. 1997 May;9(5):799-803
7479938 - Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11066-70
1538783 - Nature. 1992 Mar 5;356(6364):63-6
23916894 - Brain Behav Immun. 2013 Nov;34:98-107
21123584 - J Neurosci. 2010 Dec 1;30(48):16383-90
19540601 - J Neuroimmunol. 2009 Aug 18;213(1-2):60-8
7860709 - J Neuroimmunol. 1995 Feb;56(2):135-41
24123686 - J Immunol. 2013 Nov 15;191(10):4960-8
10605010 - J Immunol. 2000 Jan 1;164(1):183-90
10884312 - J Neurosci. 2000 Jul 15;20(14):5283-91
9670842 - J Neuroimmunol. 1998 Jul 1;87(1-2):27-32
19870180 - J Exp Med. 1933 Jun 30;58(1):39-53
10075984 - J Exp Med. 1999 Mar 15;189(6):1005-10
15879087 - J Immunol. 2005 May 15;174(10):5950-8
9603475 - Eur J Immunol. 1998 May;28(5):1681-8
8618840 - Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12041-5
20953201 - Nat Immunol. 2010 Dec;11(12):1093-101
21652010 - J Neuroimmunol. 2011 Jul;236(1-2):111-7
24920622 - J Neurosci. 2014 Jun 11;34(24):8175-85
17384649 - Nat Med. 2007 Apr;13(4):423-31
16301624 - J Immunol. 2005 Dec 1;175(11):7202-8
9362528 - J Exp Med. 1997 Nov 17;186(10):1677-87
7621871 - Eur J Immunol. 1995 Jul;25(7):1951-9
22458983 - J Neuroimmunol. 2012 May 15;246(1-2):85-95
23746653 - Am J Pathol. 2013 Aug;183(2):516-25
15964696 - Neuroscience. 2005;134(1):199-205
11006371 - N Engl J Med. 2000 Sep 28;343(13):938-52
8920851 - J Exp Med. 1996 Nov 1;184(5):1609-17
9670859 - J Neuroimmunol. 1998 Jul 1;87(1-2):171-8
24269558 - Am J Pathol. 2014 Feb;184(2):507-19
7689581 - J Neuroimmunol. 1993 Jul;46(1-2):113-21
22150037 - N Engl J Med. 2011 Dec 8;365(23):2188-97
9436789 - Glia. 1998 Jan;22(1):72-85
19890056 - J Immunol. 2009 Dec 1;183(11):7169-77
21212154 - Int Immunol. 2011 Feb;23(2):139-48
24111507 - Clin Exp Immunol. 2014 Jan;175(1):41-8
1589800 - Science. 1992 May 22;256(5060):1210-3
9756642 - Cell Immunol. 1998 Sep 15;188(2):118-24
9338786 - Nature. 1997 Oct 16;389(6652):737-42
24531377 - Nat Med. 2014 Mar;20(3):272-82
11701779 - J Neurol Neurosurg Psychiatry. 2001 Dec;71 Suppl 2:ii16-9
9663557 - J Neuroimmunol. 1998 Jun 15;86(2):123-33
16206232 - Eur J Immunol. 2005 Nov;35(11):3343-52
24871874 - Neurology. 2014 Jul 15;83(3):278-86
10092079 - Eur J Immunol. 1999 Mar;29(3):774-80
10755620 - Immunity. 2000 Mar;12(3):335-45
18835435 - Brain Behav Immun. 2009 Jan;23(1):92-100
22079990 - J Immunol. 2012 Jan 1;188(1):29-36
12849456 - Lancet Neurol. 2002 Aug;1(4):232-41
15657292 - J Exp Med. 2005 Jan 17;201(2):233-40
24652058 - Acta Neuropathol. 2014 Sep;128(3):319-31
16386239 - Cell Immunol. 2005 Oct;237(2):123-30
24563023 - Acta Neuropathol. 2014 Aug;128(2):231-46
9427610 - Nat Med. 1998 Jan;4(1):78-83
10449104 - Neurology. 1999 Aug 11;53(3):457-65
16585503 - Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6
18802481 - J Clin Invest. 2008 Oct;118(10):3420-30
21731726 - PLoS One. 2011;6(6):e21386
8871615 - J Immunol. 1996 Oct 15;157(8):3223-7
20813772 - Mult Scler. 2011 Jan;17 (1):2-15
8976182 - J Exp Med. 1996 Dec 1;184(6):2271-8
6165588 - Eur J Immunol. 1981 Mar;11(3):195-9
16921173 - Brain. 2006 Dec;129(Pt 12):3165-72
18354171 - J Immunol. 2008 Apr 1;180(7):4495-506
16675847 - FASEB J. 2006 May;20(7):896-905
22368274 - J Immunol. 2012 Apr 1;188(7):3188-98
16802293 - Ann Neurol. 2006 Jul;60(1):12-21
25056715 - Eur J Immunol. 2014 Oct;44(10):2903-17
9590229 - J Immunol. 1998 May 15;160(10):4822-30
22035960 - J Neuroimmunol. 2011 Dec 15;240-241:97-103
19234157 - J Immunol. 2009 Mar 1;182(5):2628-40
15931212 - Nature. 2005 Jun 2;435(7042):598-604
22443691 - Autoimmunity. 2012 Aug;45(5):388-99
22837037 - Nat Neurosci. 2012 Jul 26;15(8):1074-7
16301612 - J Immunol. 2005 Dec 1;175(11):7103-7
15885305 - J Neuroimmunol. 2005 Jun;163(1-2):24-30
10852536 - Ann Neurol. 2000 Jun;47(6):707-17
22605909 - P T. 2012 Mar;37(3):175-84
21197107 - Autoimmune Dis. 2010 Dec 15;2011:164608
17917672 - Nat Rev Immunol. 2007 Nov;7(11):904-12
20303295 - Immunity. 2010 Mar 26;32(3):414-25
8780061 - Neurology. 1996 Apr;46(4):907-11
11101868 - Nat Immunol. 2000 Dec;1(6):475-82
9151795 - J Clin Invest. 1997 May 1;99(9):2225-31
7689582 - J Neuroimmunol. 1993 Jul;46(1-2):123-8
19339255 - Brain. 2009 May;132(Pt 5):1175-89
23596391 - Front Cell Neurosci. 2013 Apr 08;7:34
10064079 - Eur J Immunol. 1999 Feb;29(2):626-32
9182689 - J Exp Med. 1997 Jun 16;185(12):2177-82
11125313 - Eur Cytokine Netw. 2000 Dec;11(4):677-81
21248152 - J Leukoc Biol. 2011 Apr;89(4):557-63
23307732 - Science. 2013 Jan 11;339(6116):156-61
9348316 - J Exp Med. 1997 Nov 3;186(9):1585-90
24639677 - Front Immunol. 2014 Mar 07;5:87
22848713 - PLoS One. 2012;7(7):e42088
8598493 - J Immunol. 1996 Jan 1;156(1):5-7
24372081 - Br J Pharmacol. 2014 Apr;171(7):1706-21
19664372 - Curr Neurol Neurosci Rep. 2009 Sep;9(5):411-7
22949039 - Stem Cells. 2012 Dec;30(12):2820-9
20951792 - Brain Behav Immun. 2011 Jul;25(5):932-7
9888990 - Mol Cell Neurosci. 1998 Dec;12(6):376-89
21373721 - Mol Med. 2011 May-Jun;17(5-6):442-7
17634104 - BMC Immunol. 2007 Jul 16;8:10
21516112 - Nat Immunol. 2011 Jun;12(6):560-7
18703004 - Lancet Neurol. 2008 Sep;7(9):796-804
17828272 - Nat Med. 2007 Oct;13(10):1173-5
20687208 - Ann Neurol. 2010 Oct;68(4):465-76
24572363 - Nature. 2014 Mar 20;507(7492):366-70
12610626 - Nature. 2003 Feb 13;421(6924):744-8
3110648 - Neurology. 1987 Jul;37(7):1097-102
23577171 - PLoS One. 2013;8(4):e60862
16297160 - Clin Exp Immunol. 2005 Dec;142(3):481-9
3131876 - Science. 1988 May 27;240(4856):1169-76
16633347 - Nat Med. 2006 May;12(5):518-25
10580814 - J Neuroimmunol. 1999 Nov 1;101(1):61-7
9853527 - Hum Gene Ther. 1998 Nov 20;9(17):2605-17
20483737 - J Immunol. 2010 Jun 15;184(12):7144-53
19075395 - J Clin Invest. 2009 Jan;119(1):61-9
24157130 - J Neuroimmunol. 2013 Dec 15;265(1-2):124-7
7679952 - Cell. 1993 Feb 26;72(4):551-60
22768101 - PLoS One. 2012;7(6):e39625
24481666 - Glia. 2014 May;62(5):680-91
23221338 - J Clin Invest. 2013 Jan;123(1):247-60
8820272 - Immunol Today. 1996 Mar;17(3):138-46
18156204 - Am J Pathol. 2008 Jan;172(1):146-55
12244307 - Nat Immunol. 2002 Oct;3(10):944-50
21992960 - Clin Immunol. 2011 Dec;141(3):348-56
23401502 - Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3543-8
15931287 - Clin Med Res. 2003 Jan;1(1):57-60
10488808 - Arch Neurol. 1999 Sep;56(9):1079-84
17923502 - J Exp Med. 2007 Oct 29;204(11):2591-602
19050244 - J Immunol. 2008 Dec 15;181(12):8278-87
11402297 - Gene Ther. 2001 Jan;8(1):13-9
10737797 - Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3412-7
19759299 - J Neurosci. 2009 Sep 16;29(37):11511-22
20399501 - Mol Immunol. 2010 Jun;47(10):1890-8
19933767 - Brain. 2009 Dec;132(Pt 12):3329-41
8691133 - J Exp Med. 1996 Jul 1;184(1):19-29
22948090 - J Neuroimmunol. 2013 Jan 15;254(1-2):165-9
21804537 - Nat Neurosci. 2011 Jul 31;14(9):1142-9
1732276 - J Neuroimmunol. 1992 Feb;36(2-3):105-15
22714021 - Nat Rev Neurosci. 2012 Jun 20;13(7):507-14
21425186 - Ann Neurol. 2011 Apr;69(4):721-34
23890271 - J Neuroinflammation. 2013 Jul 27;10:94
3139757 - J Immunol. 1988 Oct 1;141(7):2407-12
11535634 - J Exp Med. 2001 Sep 3;194(5):669-76
15812814 - Glia. 2005 Aug 15;51(3):235-40
19234160 - J Immunol. 2009 Mar 1;182(5):2665-71
21653838 - J Neurosci. 2011 Jun 8;31(23):8329-41
21359213 - PLoS One. 2011 Feb 16;6(2):e17103
22547654 - J Exp Med. 2012 May 7;209(5):1001-10
11956029 - Eur Cytokine Netw. 2002 Jan-Mar;13(1):110-4
References_xml – volume: 45
  start-page: 388
  issue: 5
  year: 2012
  end-page: 399
  ident: 127
  article-title: Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis
– volume: 157
  start-page: 3223
  issue: 8
  year: 1996
  end-page: 3227
  ident: 46
  article-title: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
– volume: 13
  start-page: 1173
  issue: 10
  year: 2007
  end-page: 1175
  ident: 86
  article-title: Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
– volume: 450
  start-page: 566
  issue: 7169
  year: 2007
  end-page: 569
  ident: 112
  article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function
– volume: 184
  start-page: 507
  issue: 2
  year: 2014
  end-page: 519
  ident: 199
  article-title: PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases
– volume: 68
  start-page: 369
  issue: 3
  year: 2010
  end-page: 383
  ident: 138
  article-title: B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
– volume: 24
  start-page: 641
  issue: 4
  year: 2010
  end-page: 651
  ident: 43
  article-title: Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
– volume: 13
  start-page: 507
  issue: 7
  year: 2012
  end-page: 514
  ident: 18
  article-title: Will the real multiple sclerosis please stand up?
– volume: 110
  start-page: 3543
  issue: 9
  year: 2013
  end-page: 3548
  ident: 173
  article-title: Targeting estrogen receptor beta in microglia and T cells to treat experimental autoimmune encephalomyelitis
– volume: 7
  issue: 6
  year: 2012
  ident: 160
  article-title: Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis
– volume: 192
  start-page: 393
  issue: 3
  year: 2000
  end-page: 404
  ident: 98
  article-title: Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
– volume: 31
  start-page: 8329
  issue: 23
  year: 2011
  end-page: 8341
  ident: 201
  article-title: Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis
– volume: 123
  start-page: 247
  issue: 1
  year: 2013
  end-page: 260
  ident: 103
  article-title: IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
– volume: 8
  start-page: 13
  issue: 1
  year: 2001
  end-page: 19
  ident: 59
  article-title: Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice
– volume: 161
  start-page: 3299
  issue: 7
  year: 1998
  end-page: 3306
  ident: 63
  article-title: IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
– volume: 97
  start-page: 3412
  issue: 7
  year: 2000
  end-page: 3417
  ident: 15
  article-title: Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor
– volume: 25
  start-page: 24
  issue: 8
  year: 2012
  end-page: 29
  ident: 3
  article-title: Multiple sclerosis: a comprehensive review for the physician assistant
– volume: 166
  start-page: 7579
  issue: 12
  year: 2001
  end-page: 7587
  ident: 90
  article-title: Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice
– volume: 182
  start-page: 2665
  issue: 5
  year: 2009
  end-page: 2671
  ident: 80
  article-title: IL-17 signaling-independent central nervous system autoimmunity is negatively regulated by TGF-
– volume: 7
  start-page: 796
  issue: 9
  year: 2008
  end-page: 804
  ident: 83
  article-title: Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
– volume: 184
  start-page: 1609
  issue: 5
  year: 1996
  end-page: 1617
  ident: 118
  article-title: Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE)
– volume: 1
  start-page: 232
  issue: 4
  year: 2002
  end-page: 241
  ident: 196
  article-title: The role of nitric oxide in multiple sclerosis
– volume: 154
  start-page: 4309
  issue: 9
  year: 1995
  end-page: 4321
  ident: 169
  article-title: Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting—phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared
– volume: 56
  start-page: 1079
  issue: 9
  year: 1999
  end-page: 1084
  ident: 9
  article-title: Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics
– volume: 99
  start-page: 2225
  issue: 9
  year: 1997
  end-page: 2231
  ident: 100
  article-title: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN- secreting TH1 cells in humans
– volume: 164
  start-page: 183
  issue: 1
  year: 2000
  end-page: 190
  ident: 109
  article-title: Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
– volume: 5
  year: 2014
  ident: 142
  article-title: Human NK cells: from surface receptors to the therapy of leukemias and solid tumors
– volume: 36
  start-page: 105
  issue: 2-3
  year: 1992
  end-page: 115
  ident: 48
  article-title: Effect of anti-interferon- and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse
– volume: 6
  issue: 2
  year: 2011
  ident: 140
  article-title: Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis
– volume: 13
  start-page: 423
  issue: 4
  year: 2007
  end-page: 431
  ident: 107
  article-title: Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
– volume: 237
  start-page: 123
  issue: 2
  year: 2005
  end-page: 130
  ident: 71
  article-title: Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
– volume: 103
  start-page: 5941
  issue: 15
  year: 2006
  end-page: 5946
  ident: 158
  article-title: Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
– volume: 356
  start-page: 63
  issue: 6364
  year: 1992
  end-page: 66
  ident: 23
  article-title: Prevention of experimental autoimmune encephalomyelitis by antibodies against 4 1 integrin
– volume: 81
  start-page: 374
  issue: 3
  year: 2005
  end-page: 389
  ident: 163
  article-title: Microglial cell activation and proliferation precedes the onset of CNS autoimmunity
– volume: 4
  start-page: 78
  issue: 1
  year: 1998
  end-page: 83
  ident: 36
  article-title: TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
– volume: 8
  issue: 2
  year: 2013
  ident: 180
  article-title: Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil
– volume: 32
  start-page: 414
  issue: 3
  year: 2010
  end-page: 425
  ident: 185
  article-title: Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis
– volume: 21
  start-page: 1883
  issue: 9
  year: 2012
  end-page: 1897
  ident: 207
  article-title: Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice
– volume: 59
  start-page: 166
  issue: 1
  year: 2011
  end-page: 176
  ident: 193
  article-title: Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease
– year: 2014
  ident: 49
  article-title: Innate IFN- promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages
– volume: 30
  start-page: 2820
  issue: 12
  year: 2012
  end-page: 2829
  ident: 206
  article-title: Immunomodulation by transplanted human embryonic stem cell-derived oligodendroglial progenitors in experimental autoimmune encephalomyelitis
– volume: 46
  start-page: 907
  issue: 4
  year: 1996
  end-page: 911
  ident: 8
  article-title: Defining the clinical course of multiple sclerosis: results of an international survey
– volume: 151
  start-page: 2132
  issue: 4
  year: 1993
  end-page: 2141
  ident: 195
  article-title: Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
– volume: 17
  start-page: 138
  issue: 3
  year: 1996
  end-page: 146
  ident: 53
  article-title: The expanding universe of T-cell subsets: Th1, Th2 and more
– volume: 2011
  year: 2011
  end-page: 11
  ident: 198
  article-title: Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment
– volume: 11
  start-page: 195
  issue: 3
  year: 1981
  end-page: 199
  ident: 22
  article-title: The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
– volume: 209
  start-page: 1001
  issue: 5
  year: 2012
  end-page: 1010
  ident: 141
  article-title: B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
– volume: 187
  start-page: 1517
  issue: 9
  year: 1998
  end-page: 1528
  ident: 30
  article-title: Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
– volume: 22
  start-page: 72
  issue: 1
  year: 1998
  end-page: 85
  ident: 168
  article-title: Mature microglia resemble immature antigen-presenting cells
– volume: 46
  start-page: 123
  issue: 1-2
  year: 1993
  end-page: 128
  ident: 66
  article-title: Interferon α- and interleukin-4-secreting cells in multiple sclerosis
– volume: 141
  start-page: 2407
  issue: 7
  year: 1988
  end-page: 2412
  ident: 178
  article-title: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production
– volume: 23
  start-page: 92
  issue: 1
  year: 2009
  end-page: 100
  ident: 64
  article-title: Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy
– volume: 35
  start-page: 76
  issue: 1
  year: 2005
  end-page: 85
  ident: 92
  article-title: Specificity, magnitude, and kinetics of MOG-specific CD8 T cell responses during experimental autoimmune encephalomyelitis
– volume: 65
  start-page: 499
  issue: 5
  year: 2009
  end-page: 509
  ident: 85
  article-title: T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-
– volume: 90
  start-page: 187
  issue: 3-4
  year: 1997
  end-page: 202
  ident: 68
  article-title: Increased in vitro induced CD4+ and CDs+ T cell IFN- and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis
– volume: 28
  start-page: 1681
  issue: 5
  year: 1998
  end-page: 1688
  ident: 144
  article-title: Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis
– volume: 11
  start-page: 677
  issue: 4
  year: 2000
  end-page: 681
  ident: 67
  article-title: Interferon- and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients
– volume: 30
  start-page: 16383
  issue: 48
  year: 2010
  end-page: 16390
  ident: 203
  article-title: NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease
– volume: 45
  start-page: 68
  year: 2013
  end-page: 79
  ident: 87
  article-title: Promotion and prevention of autoimmune disease by CD8 T cells
– volume: 171
  start-page: 1706
  issue: 7
  year: 2013
  end-page: 1721
  ident: 94
  article-title: Blocking initial infiltration of pioneer CD8 T cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice
– volume: 53
  start-page: 457
  issue: 3
  year: 1999
  end-page: 465
  ident: 40
  article-title: TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group
– volume: 35
  start-page: 3343
  issue: 11
  year: 2005
  end-page: 3352
  ident: 117
  article-title: Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
– volume: 130
  start-page: 572
  issue: 4
  year: 2010
  end-page: 588
  ident: 44
  article-title: Peroxisome proliferator-activated receptor agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis
– volume: 156
  start-page: 5
  issue: 1
  year: 1996
  end-page: 7
  ident: 45
  article-title: Mice with a disrupted IFN- gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
– volume: 172
  start-page: 146
  issue: 1
  year: 2008
  end-page: 155
  ident: 104
  article-title: Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
– volume: 6
  issue: 7
  year: 2009
  ident: 171
  article-title: Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice
– volume: 9
  start-page: 411
  issue: 5
  year: 2009
  end-page: 417
  ident: 21
  article-title: Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis
– volume: 119
  start-page: 61
  issue: 1
  year: 2009
  end-page: 69
  ident: 82
  article-title: IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
– volume: 365
  start-page: 2188
  issue: 23
  year: 2011
  end-page: 2197
  ident: 99
  article-title: Inflammatory cortical demyelination in early multiple sclerosis
– volume: 101
  start-page: 61
  issue: 1
  year: 1999
  end-page: 67
  ident: 128
  article-title: The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages
– volume: 92
  start-page: 12041
  issue: 26
  year: 1995
  end-page: 12045
  ident: 197
  article-title: Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
– volume: 58
  start-page: 1847
  issue: 15
  year: 2010
  end-page: 1857
  ident: 205
  article-title: Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis
– volume: 34
  start-page: 8175
  issue: 24
  year: 2014
  end-page: 8185
  ident: 183
  article-title: Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE
– volume: 29
  start-page: 11511
  issue: 37
  year: 2009
  end-page: 11522
  ident: 186
  article-title: Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS
– volume: 83
  start-page: 278
  issue: 3
  year: 2013
  end-page: 286
  ident: 7
  article-title: Defining the clinical course of multiple sclerosis: the 2013 revisions
– volume: 44
  start-page: 22
  issue: 1
  year: 2008
  end-page: 25
  ident: 51
  article-title: IL17 and IFN production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis
– volume: 240
  start-page: 1169
  issue: 4856
  year: 1988
  end-page: 1176
  ident: 110
  article-title: Interleukin-2: inception, impact, and implications
– volume: 9
  start-page: 799
  issue: 5
  year: 1997
  end-page: 803
  ident: 56
  article-title: Experimental autoimmune encephalomyelitis in IL-4-deficient mice
– volume: 12
  start-page: 518
  issue: 5
  year: 2006
  end-page: 525
  ident: 122
  article-title: Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE
– volume: 7
  start-page: 277
  issue: 5
  year: 2001
  end-page: 284
  ident: 52
  article-title: Randomized study of antibodies to IFN- and TNF-α in secondary progressive multiple sclerosis
– volume: 507
  start-page: 366
  issue: 7492
  year: 2014
  end-page: 370
  ident: 136
  article-title: IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
– volume: 182
  start-page: 2628
  issue: 5
  year: 2009
  end-page: 2640
  ident: 187
  article-title: Transgenic inhibition of astroglial NF- B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation
– volume: 66
  start-page: 483
  issue: 4
  year: 2009
  end-page: 489
  ident: 159
  article-title: Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis
– volume: 260
  start-page: 17
  issue: 1-2
  year: 2013
  end-page: 27
  ident: 93
  article-title: CD8+ T cell help is required for efficient induction of EAE in Lewis rats
– volume: 37
  start-page: 1097
  issue: 7
  year: 1987
  end-page: 1102
  ident: 41
  article-title: Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system
– volume: 175
  start-page: 41
  issue: 1
  year: 2014
  end-page: 48
  ident: 39
  article-title: Blockade of tumour necrosis factor- in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology
– volume: 6
  issue: 11
  year: 2011
  ident: 184
  article-title: Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis
– volume: 29
  start-page: 774
  issue: 3
  year: 1999
  end-page: 780
  ident: 38
  article-title: TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis
– volume: 175
  start-page: 5875
  issue: 9
  year: 2005
  end-page: 5884
  ident: 34
  article-title: Apoptosis of oligodendrocytes via fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis
– volume: 132
  start-page: 1175
  issue: 5
  year: 2009
  end-page: 1189
  ident: 25
  article-title: The relation between inflammation and neurodegeneration in multiple sclerosis brains
– volume: 1219
  start-page: 116
  year: 2008
  end-page: 126
  ident: 166
  article-title: A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain
– volume: 34
  start-page: 98
  year: 2013
  end-page: 107
  ident: 192
  article-title: Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis
– volume: 87
  start-page: 27
  issue: 1-2
  year: 1998
  end-page: 32
  ident: 69
  article-title: Elevated serum levels of IFN- , IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage
– volume: 20
  start-page: 272
  year: 2014
  end-page: 282
  ident: 125
  article-title: FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
– volume: 175
  start-page: 3025
  issue: 5
  year: 2005
  end-page: 3032
  ident: 106
  article-title: Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system
– volume: 128
  start-page: 319
  issue: 3
  year: 2014
  end-page: 331
  ident: 165
  article-title: Microglia: unique and common features with other tissue macrophages
– volume: 6
  issue: 6
  year: 2011
  ident: 119
  article-title: T regulatory cells are markers of disease activity in multiple sclerosis patients
– volume: 140
  start-page: 1506
  issue: 5
  year: 1988
  end-page: 1510
  ident: 47
  article-title: Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-
– volume: 43
  start-page: 678
  issue: 3
  year: 2011
  end-page: 689
  ident: 208
  article-title: Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis
– volume: 184
  start-page: 19
  issue: 1
  year: 1996
  end-page: 29
  ident: 123
  article-title: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
– volume: 183
  start-page: 7169
  issue: 11
  year: 2009
  end-page: 7177
  ident: 79
  article-title: Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes
– volume: 72
  start-page: 551
  issue: 4
  year: 1993
  end-page: 560
  ident: 14
  article-title: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
– volume: 186
  start-page: 1585
  issue: 9
  year: 1997
  end-page: 1590
  ident: 37
  article-title: Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting
– volume: 68
  start-page: 465
  issue: 4
  year: 2010
  end-page: 476
  ident: 26
  article-title: Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords
– volume: 265
  start-page: 124
  issue: 1-2
  year: 2013
  end-page: 127
  ident: 155
  article-title: Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis
– volume: 254
  start-page: 165
  issue: 1-2
  year: 2013
  end-page: 169
  ident: 152
  article-title: Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
– volume: 185
  start-page: 2177
  issue: 12
  year: 1997
  end-page: 2182
  ident: 35
  article-title: Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis
– volume: 141
  start-page: 348
  issue: 3
  year: 2011
  end-page: 356
  ident: 156
  article-title: Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
– volume: 118
  start-page: 3420
  issue: 10
  year: 2008
  end-page: 3430
  ident: 134
  article-title: Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
– volume: 177
  start-page: 566
  issue: 1
  year: 2006
  end-page: 573
  ident: 81
  article-title: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
– volume: 69
  start-page: 721
  issue: 4
  year: 2011
  end-page: 734
  ident: 145
  article-title: Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation
– volume: 201
  start-page: 233
  issue: 2
  year: 2005
  end-page: 240
  ident: 78
  article-title: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
– volume: 343
  start-page: 938
  issue: 13
  year: 2000
  end-page: 952
  ident: 5
  article-title: Multiple sclerosis
– volume: 359
  start-page: 1786
  issue: 17
  year: 2008
  end-page: 1801
  ident: 101
  article-title: Alemtuzumab vs. interferon beta-1a in early multiple sclerosis
– volume: 188
  start-page: 29
  issue: 1
  year: 2012
  end-page: 36
  ident: 170
  article-title: The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood
– volume: 554
  start-page: 146
  year: 2013
  end-page: 150
  ident: 167
  article-title: Up-regulation of spinal microglial Iba-1 expression persists after resolution of neuropathic pain hypersensitivity
– volume: 188
  start-page: 118
  issue: 2
  year: 1998
  end-page: 124
  ident: 62
  article-title: Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery
– volume: 191
  start-page: 4960
  issue: 10
  year: 2013
  end-page: 4968
  ident: 96
  article-title: The role of CD8+T cells and their local interaction with CD4+T cells in myelin oligodendrocyte glycoprotein35-55- induced experimental autoimmune encephalomyelitis
– volume: 435
  start-page: 598
  issue: 7042
  year: 2005
  end-page: 604
  ident: 105
  article-title: Regulation of immunity by self-reactive T cells
– volume: 247
  start-page: 86
  issue: 1-2
  year: 2012
  end-page: 94
  ident: 129
  article-title: Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions
– volume: 8, article 10
  year: 2007
  ident: 172
  article-title: Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis
– volume: 17
  start-page: 64
  issue: 1
  year: 2011
  end-page: 70
  ident: 174
  article-title: MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway
– volume: 213
  start-page: 60
  issue: 1-2
  year: 2009
  end-page: 68
  ident: 95
  article-title: Pathogenic MOG-reactive CD8 T cells require MOG-reactive CD4 T cells for sustained CNS inflammation during chronic EAE
– volume: 86
  start-page: 123
  issue: 2
  year: 1998
  end-page: 133
  ident: 153
  article-title: A role for natural killer cells in the immunopathogenesis of multiple sclerosis
– volume: 184
  start-page: 2271
  issue: 6
  year: 1996
  end-page: 2278
  ident: 133
  article-title: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice
– volume: 7
  year: 2013
  ident: 164
  article-title: Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair
– volume: 179
  start-page: 958
  issue: 2
  year: 2007
  end-page: 966
  ident: 108
  article-title: The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells
– volume: 101
  start-page: 2428
  issue: 8
  year: 2004
  end-page: 2433
  ident: 97
  article-title: Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood
– volume: 25
  start-page: 1951
  issue: 7
  year: 1995
  end-page: 1959
  ident: 13
  article-title: A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Y expression of encephalitogenic T cells
– volume: 29
  start-page: 626
  issue: 2
  year: 1999
  end-page: 632
  ident: 32
  article-title: Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1
– volume: 12
  start-page: 560
  issue: 6
  year: 2011
  end-page: 567
  ident: 77
  article-title: ROR 3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
– volume: 92
  start-page: 11066
  issue: 24
  year: 1995
  end-page: 11070
  ident: 28
  article-title: Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis
– volume: 58
  start-page: 39
  issue: 1
  year: 1933
  end-page: 53
  ident: 10
  article-title: Observations on attempts to produce acute disseminated encephalomyelitis in monkeys
– volume: 246
  start-page: 85
  issue: 1-2
  year: 2012
  end-page: 95
  ident: 130
  article-title: Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
– volume: 129, part 12
  start-page: 3165
  year: 2006
  end-page: 3172
  ident: 202
  article-title: Remyelination is extensive in a subset of multiple sclerosis patients
– volume: 25
  start-page: 1554
  issue: 8
  year: 2011
  end-page: 1568
  ident: 190
  article-title: BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions
– volume: 174
  start-page: 5950
  issue: 10
  year: 2005
  end-page: 5958
  ident: 124
  article-title: TGF- 1 uses distinct mechanisms to inhibit IFN- expression in CD4+ T cells at priming and at recall: Differential involvement of Stat4 and T-bet
– volume: 62
  start-page: 680
  issue: 5
  year: 2014
  end-page: 691
  ident: 200
  article-title: Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination
– volume: 87
  start-page: 171
  issue: 1-2
  year: 1998
  end-page: 178
  ident: 57
  article-title: Acute and relapsing experimental autoimmune encephalomyelitis in IL-4- and α/ T cell-deficient C57BL/6 mice
– volume: 14
  start-page: 1142
  issue: 9
  year: 2011
  end-page: 1150
  ident: 162
  article-title: Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
– volume: 13
  start-page: 110
  issue: 1
  year: 2002
  end-page: 114
  ident: 70
  article-title: Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis
– volume: 51
  start-page: 235
  issue: 3
  year: 2005
  end-page: 240
  ident: 189
  article-title: Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis
– volume: 16
  start-page: 1401
  issue: 10
  year: 2013
  end-page: 1408
  ident: 210
  article-title: Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
– volume: 3
  start-page: 944
  issue: 10
  year: 2002
  end-page: 950
  ident: 135
  article-title: B cells regulate autoimmunity by provision of IL-10
– volume: 17
  start-page: 442
  issue: 5-6
  year: 2011
  end-page: 447
  ident: 2
  article-title: The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis
– volume: 15
  start-page: 1074
  issue: 8
  year: 2012
  end-page: 1077
  ident: 20
  article-title: Animal models of multiple sclerosis: the good, the bad and the bottom line
– volume: 17
  start-page: 2
  issue: 1
  year: 2011
  end-page: 15
  ident: 182
  article-title: Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration
– volume: 37
  start-page: 465
  issue: 6-7
  year: 2004
  end-page: 471
  ident: 31
  article-title: Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression
– volume: 175
  start-page: 7202
  issue: 11
  year: 2005
  end-page: 7208
  ident: 55
  article-title: Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response
– volume: 46
  start-page: 113
  issue: 1-2
  year: 1993
  end-page: 121
  ident: 24
  article-title: Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice
– volume: 11
  start-page: 1093
  year: 2010
  end-page: 1101
  ident: 115
  article-title: IL-35-mediated induction of a potent regulatory T cell population
– volume: 71
  start-page: ii16
  issue: 2
  year: 2001
  end-page: ii19
  ident: 6
  article-title: Natural history of multiple sclerosis
– volume: 186
  start-page: 1677
  issue: 10
  year: 1997
  end-page: 1687
  ident: 146
  article-title: Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
– volume: 27
  start-page: 1973
  issue: 8
  year: 1997
  end-page: 1981
  ident: 29
  article-title: Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system
– volume: 163
  start-page: 24
  issue: 1-2
  year: 2005
  end-page: 30
  ident: 147
  article-title: Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis
– volume: 236
  start-page: 111
  issue: 1-2
  year: 2011
  end-page: 117
  ident: 157
  article-title: Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon- and interferon- combined with low-dose oral steroids
– volume: 6
  issue: 3
  year: 2011
  ident: 121
  article-title: Intracerebral human regulatory T cells: analysis of CD4+CD25+FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients
– volume: 389
  start-page: 737
  issue: 6652
  year: 1997
  end-page: 742
  ident: 111
  article-title: A CD4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
– volume: 175
  start-page: 7103
  issue: 11
  year: 2005
  end-page: 7107
  ident: 132
  article-title: Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor α, and Th2 cells
– volume: 20
  start-page: 896
  issue: 7
  year: 2006
  end-page: 905
  ident: 148
  article-title: The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system
– volume: 13
  start-page: 257
  issue: 3
  year: 2001
  end-page: 264
  ident: 17
  article-title: Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis
– volume: 132, part 12
  start-page: 3329
  year: 2009
  end-page: 3341
  ident: 84
  article-title: Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
– volume: 66
  start-page: 739
  issue: 6
  year: 2009
  end-page: 753
  ident: 19
  article-title: Multiple sclerosis: distribution of inflammatory cells in newly forming lesions
– volume: 23
  start-page: 139
  issue: 2
  year: 2011
  end-page: 148
  ident: 154
  article-title: Impaired IFN-gamma production and proliferation of NK cells in multiple sclerosis
– volume: 183
  start-page: 516
  issue: 2
  year: 2013
  end-page: 525
  ident: 209
  article-title: Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis
– volume: 7
  issue: 7
  year: 2012
  ident: 194
  article-title: IFN- signaling to astrocytes protects from autoimmune mediated neurological disability
– volume: 181
  start-page: 8278
  issue: 12
  year: 2008
  end-page: 8287
  ident: 137
  article-title: B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit
– volume: 339
  start-page: 156
  issue: 6116
  year: 2013
  end-page: 161
  ident: 175
  article-title: Microglia: scapegoat, saboteur, or something else?
– volume: 56
  start-page: 135
  issue: 2
  year: 1995
  end-page: 141
  ident: 33
  article-title: Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I
– volume: 20
  start-page: 5283
  issue: 14
  year: 2000
  end-page: 5291
  ident: 151
  article-title: Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells
– volume: 25
  start-page: 932
  issue: 5
  year: 2011
  end-page: 937
  ident: 75
  article-title: IL-23 modulated myelin-specific T cells induce EAE via an IFN driven, IL-17 independent pathway
– volume: 128
  start-page: 231
  issue: 2
  year: 2014
  end-page: 246
  ident: 204
  article-title: Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination
– volume: 89
  start-page: 557
  issue: 4
  year: 2011
  end-page: 563
  ident: 177
  article-title: Obstacles and opportunities for understanding macrophage polarization
– volume: 42
  start-page: 717
  issue: 6
  year: 2006
  end-page: 727
  ident: 179
  article-title: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy
– volume: 421
  start-page: 744
  issue: 6924
  year: 2003
  end-page: 748
  ident: 74
  article-title: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
– volume: 134
  start-page: 199
  issue: 1
  year: 2005
  end-page: 205
  ident: 16
  article-title: Lesional accumulation of P2X receptor macrophages in rat CNS during experimental autoimmune encephalomyelitis
– volume: 256
  start-page: 1210
  issue: 5060
  year: 1992
  end-page: 1213
  ident: 89
  article-title: Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice
– volume: 47
  start-page: 1890
  issue: 10
  year: 2010
  end-page: 1898
  ident: 54
  article-title: Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis
– volume: 12
  start-page: 335
  issue: 3
  year: 2000
  end-page: 345
  ident: 126
  article-title: Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events
– volume: 43
  start-page: 115
  issue: 1
  year: 2013
  end-page: 124
  ident: 191
  article-title: Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis
– volume: 10
  start-page: 94
  year: 2013
  ident: 102
  article-title: Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
– volume: 37
  start-page: 3021
  issue: 11
  year: 2007
  end-page: 3029
  ident: 113
  article-title: IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells
– volume: 7
  start-page: 904
  issue: 11
  year: 2007
  end-page: 912
  ident: 11
  article-title: The origin and application of experimental autoimmune encephalomyelitis
– volume: 160
  start-page: 4822
  issue: 10
  year: 1998
  end-page: 4830
  ident: 58
  article-title: A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4 deficient C57BL/6 mice and BALB/c mice
– volume: 188
  start-page: 3188
  issue: 7
  year: 2012
  end-page: 3198
  ident: 139
  article-title: A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand
– volume: 9
  start-page: 2605
  issue: 17
  year: 1998
  end-page: 2617
  ident: 60
  article-title: Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination
– volume: 62
  start-page: 452
  issue: 3
  year: 2014
  end-page: 467
  ident: 188
  article-title: Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination
– volume: 256
  start-page: 1213
  issue: 5060
  year: 1992
  end-page: 1215
  ident: 88
  article-title: Role of CD8+ T cells in murine experimental allergic encephalomyelitis
– volume: 12
  start-page: 376
  issue: 6
  year: 1998
  end-page: 389
  ident: 42
  article-title: Interferon- , in progression to chronic demyelination and neurological deficit following acute EAE
– volume: 184
  start-page: 7144
  issue: 12
  year: 2010
  end-page: 7153
  ident: 114
  article-title: IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10
– volume: 47
  start-page: 707
  issue: 6
  year: 2000
  end-page: 717
  ident: 161
  article-title: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination
– volume: 180
  start-page: 4495
  issue: 7
  year: 2008
  end-page: 4506
  ident: 149
  article-title: In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses
– volume: 22
  start-page: 421
  issue: 4
  year: 2008
  end-page: 430
  ident: 27
  article-title: CD4 T cells: balancing the coming and going of autoimmune-mediated inflammation in the CNS
– volume: 103
  start-page: 4222
  issue: 11
  year: 2004
  end-page: 4231
  ident: 50
  article-title: High prevalence of autoreactive, neuroantigen-specific CD8 T cells in multiple sclerosis revealed by novel flow cytometric assay
– volume: 1
  start-page: 475
  issue: 6
  year: 2000
  end-page: 482
  ident: 131
  article-title: Reciprocal regulation of polarized cytokine production by effector B and T cells
– volume: 40
  start-page: 2340
  issue: 8
  year: 2010
  end-page: 2348
  ident: 76
  article-title: EAE mediated by a non-IFN- /non-IL-17 pathway
– volume: 199
  start-page: 971
  issue: 7
  year: 2004
  end-page: 979
  ident: 116
  article-title: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
– volume: 60
  start-page: 12
  issue: 1
  year: 2006
  end-page: 21
  ident: 12
  article-title: How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis
– volume: 142
  start-page: 481
  issue: 3
  year: 2005
  end-page: 489
  ident: 181
  article-title: Macrophage activation switching: an asset for the resolution of inflammation
– volume: 10
  start-page: 514
  issue: 5
  year: 2009
  end-page: 523
  ident: 72
  article-title: C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
– volume: 1
  start-page: 57
  issue: 1
  year: 2003
  end-page: 60
  ident: 1
  article-title: Multiple sclerosis: it's not the disease you thought it was
– volume: 37
  start-page: 175
  issue: 3
  year: 2012
  end-page: 184
  ident: 4
  article-title: Multiple sclerosis review
– volume: 194
  start-page: 669
  issue: 5
  year: 2001
  end-page: 676
  ident: 91
  article-title: A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis
– volume: 8
  issue: 4
  year: 2013
  ident: 150
  article-title: Essential role of NK cells in IgG therapy for experimental autoimmune encephalomyelitis
– volume: 189
  start-page: 1005
  issue: 6
  year: 1999
  end-page: 1010
  ident: 65
  article-title: Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis
– volume: 15
  start-page: 1700
  issue: 2
  year: 2014
  end-page: 1718
  ident: 61
  article-title: Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice
– volume: 11
  start-page: 738
  issue: 11
  year: 2011
  end-page: 749
  ident: 176
  article-title: Macrophage-mediated inflammation in metabolic disease
– volume: 240-241
  start-page: 97
  year: 2011
  end-page: 103
  ident: 120
  article-title: Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse
– volume: 204
  start-page: 2591
  issue: 11
  year: 2007
  end-page: 2602
  ident: 143
  article-title: TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN- production
– volume: 8
  start-page: 913
  issue: 9
  year: 2007
  end-page: 919
  ident: 73
  article-title: Multiple sclerosis: a complicated picture of autoimmunity
– ident: 165
  doi: 10.3389/fncel.2013.00034
– ident: 142
  doi: 10.1084/jem.20111675
– ident: 175
  doi: 10.1038/nm.2266
– ident: 146
  doi: 10.1002/ana.22339
– ident: 208
  doi: 10.3727/096368911X637443
– ident: 75
  doi: 10.1038/nature01355
– ident: 135
  doi: 10.1172/JCI36030
– ident: 19
  doi: 10.1002/ana.21800
– volume: 110
  start-page: 3543
  issue: 9
  year: 2013
  ident: 174
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.1300313110
– ident: 110
  doi: 10.4049/jimmunol.164.1.183
– ident: 193
  doi: 10.1016/j.bbi.2013.07.176
– volume: 151
  start-page: 2132
  issue: 4
  year: 1993
  ident: 196
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.151.4.2132
– ident: 183
  doi: 10.1177/1352458510379243
– ident: 88
  doi: 10.1016/j.jaut.2013.06.004
– ident: 25
  doi: 10.1093/brain/awp070
– ident: 139
  doi: 10.1002/ana.22081
– ident: 28
  doi: 10.1073/pnas.92.24.11066
– ident: 178
  doi: 10.1189/jlb.0710409
– volume: 129, part 12
  start-page: 3165
  year: 2006
  ident: 203
  publication-title: Brain
– ident: 167
  doi: 10.1016/j.brainres.2008.05.004
– ident: 105
  doi: 10.2353/ajpath.2008.070690
– ident: 118
  doi: 10.1002/eji.200526065
– volume: 13
  start-page: 110
  issue: 1
  year: 2002
  ident: 71
  publication-title: European Cytokine Network
– ident: 206
  doi: 10.1002/glia.21054
– ident: 210
  doi: 10.1016/j.ajpath.2013.04.016
– ident: 133
  doi: 10.4049/jimmunol.175.11.7103
– volume: 53
  start-page: 457
  issue: 3
  year: 1999
  ident: 41
  publication-title: Neurology
  doi: 10.1212/WNL.53.3.457
– ident: 107
  doi: 10.4049/jimmunol.175.5.3025
– ident: 157
  doi: 10.1016/j.clim.2011.09.006
– ident: 185
  doi: 10.1371/journal.pone.0026921
– ident: 113
  doi: 10.1038/nature06306
– ident: 141
  doi: 10.1371/journal.pone.0017103
– ident: 188
  doi: 10.4049/jimmunol.0802954
– ident: 128
  doi: 10.3109/08916934.2012.665523
– ident: 39
  doi: 10.1111/cei.12209
– ident: 76
  doi: 10.1016/j.bbi.2010.10.001
– ident: 3
  doi: 10.1097/01720610-201208000-00005
– ident: 14
  doi: 10.1016/0092-8674(93)90074-Z
– ident: 29
  doi: 10.1002/eji.1830270822
– ident: 84
  doi: 10.1016/S1474-4422(08)70173-X
– ident: 90
  doi: 10.1126/science.256.5060.1210
– ident: 121
  doi: 10.1016/j.jneuroim.2011.09.013
– ident: 80
  doi: 10.4049/jimmunol.0901906
– ident: 103
  doi: 10.1186/1742-2094-10-94
– ident: 149
  doi: 10.1096/fj.05-5465com
– ident: 114
  doi: 10.1002/eji.200737810
– ident: 34
  doi: 10.4049/jimmunol.175.9.5875
– ident: 51
  doi: 10.1182/blood-2003-11-4025
– ident: 150
  doi: 10.4049/jimmunol.180.7.4495
– ident: 115
  doi: 10.4049/jimmunol.0902739
– ident: 74
  doi: 10.1038/ni1507
– ident: 161
  doi: 10.1371/journal.pone.0039625
– ident: 187
  doi: 10.1523/JNEUROSCI.1514-09.2009
– ident: 91
  doi: 10.4049/jimmunol.166.12.7579
– ident: 200
  doi: 10.1016/j.ajpath.2013.10.009
– ident: 163
  doi: 10.1038/nn.2887
– ident: 35
  doi: 10.1084/jem.185.12.2177
– volume: 236
  start-page: 111
  issue: 1-2
  year: 2011
  ident: 158
  publication-title: Journal of Neuroimmunology
  doi: 10.1016/j.jneuroim.2011.05.005
– ident: 69
  doi: 10.3109/00207459709000638
– ident: 93
  doi: 10.1002/eji.200425660
– ident: 117
  doi: 10.1084/jem.20031579
– ident: 52
  doi: 10.1016/j.cyto.2008.08.007
– ident: 202
  doi: 10.1523/JNEUROSCI.1028-11.2011
– ident: 94
  doi: 10.1016/j.jneuroim.2013.04.014
– ident: 148
  doi: 10.1016/j.jneuroim.2005.02.011
– ident: 53
  doi: 10.1191/135245801681137960
– ident: 140
  doi: 10.4049/jimmunol.1103354
– ident: 138
  doi: 10.4049/jimmunol.181.12.8278
– ident: 207
  doi: 10.1002/stem.1218
– ident: 63
  doi: 10.1006/cimm.1998.1365
– ident: 195
  doi: 10.1371/journal.pone.0042088
– ident: 23
  doi: 10.1038/356063a0
– ident: 160
  doi: 10.1001/archneurol.2009.50
– volume: 157
  start-page: 3223
  issue: 8
  year: 1996
  ident: 47
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.157.8.3223
– ident: 16
  doi: 10.1016/j.neuroscience.2005.04.026
– volume: 141
  start-page: 2407
  issue: 7
  year: 1988
  ident: 179
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.141.7.2407
– ident: 112
  doi: 10.1038/39614
– volume: 58
  start-page: 39
  issue: 1
  year: 1933
  ident: 10
  publication-title: The Journal of Experimental Medicine
  doi: 10.1084/jem.58.1.39
– volume: 160
  start-page: 4822
  issue: 10
  year: 1998
  ident: 59
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.160.10.4822
– ident: 50
  doi: 10.1002/eji.201444612
– ident: 171
  doi: 10.4049/jimmunol.1100421
– ident: 153
  doi: 10.1016/j.jneuroim.2012.08.009
– ident: 55
  doi: 10.1016/j.molimm.2010.03.014
– ident: 101
  doi: 10.1172/JCI119396
– ident: 49
  doi: 10.1016/0165-5728(92)90042-J
– volume: 22
  start-page: 72
  issue: 1
  year: 1998
  ident: 169
  publication-title: Glia
  doi: 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A
– ident: 30
  doi: 10.1084/jem.187.9.1517
– ident: 130
  doi: 10.1016/j.jneuroim.2012.03.020
– ident: 96
  doi: 10.1016/j.jneuroim.2009.05.017
– volume: 156
  start-page: 5
  issue: 1
  year: 1996
  ident: 46
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.156.1.5
– ident: 205
  doi: 10.1007/s00401-014-1260-8
– ident: 144
  doi: 10.1084/jem.20070634
– ident: 192
  doi: 10.1002/eji.201242679
– ident: 124
  doi: 10.1084/jem.184.1.19
– volume: 140
  start-page: 1506
  issue: 5
  year: 1988
  ident: 48
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.140.5.1506
– ident: 116
  doi: 10.1038/ni.1952
– ident: 190
  doi: 10.1002/glia.20199
– volume: 37
  start-page: 175
  issue: 3
  year: 2012
  ident: 4
  publication-title: P and T
– ident: 67
  doi: 10.1016/0165-5728(93)90241-P
– ident: 123
  doi: 10.1038/nm1402
– ident: 211
  doi: 10.1038/nn.3505
– ident: 156
  doi: 10.1016/j.jneuroim.2013.10.004
– ident: 1
  doi: 10.3121/cmr.1.1.57
– ident: 92
  doi: 10.1084/jem.194.5.669
– ident: 172
  doi: 10.1371/journal.pmed.1000113
– ident: 54
  doi: 10.1016/0167-5699(96)80606-2
– ident: 186
  doi: 10.1016/j.immuni.2010.03.004
– ident: 2
  doi: 10.2119/molmed.2011.00077
– ident: 20
  doi: 10.1038/nn.3168
– ident: 98
  doi: 10.1073/pnas.0308689100
– volume: 47
  start-page: 707
  issue: 6
  year: 2000
  ident: 162
  publication-title: Annals of Neurology
  doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
– ident: 201
  doi: 10.1002/glia.22634
– ident: 73
  doi: 10.1038/ni.1716
– ident: 43
  doi: 10.1006/mcne.1998.0725
– ident: 155
  doi: 10.1093/intimm/dxq463
– ident: 134
  doi: 10.1084/jem.184.6.2271
– ident: 137
  doi: 10.1038/nature12979
– ident: 168
  doi: 10.1016/j.neulet.2013.08.062
– ident: 37
  doi: 10.1084/jem.186.9.1585
– ident: 109
  doi: 10.4049/jimmunol.179.2.958
– ident: 159
  doi: 10.1073/pnas.0601335103
– ident: 180
  doi: 10.1016/j.ejca.2006.01.003
– ident: 12
  doi: 10.1002/ana.20913
– ident: 78
  doi: 10.1038/ni.2027
– ident: 65
  doi: 10.1016/j.bbi.2008.09.004
– ident: 197
  doi: 10.1016/S1474-4422(02)00102-3
– ident: 58
  doi: 10.1016/S0165-5728(98)00083-6
– ident: 173
  doi: 10.1186/1471-2172-8-10
– ident: 66
  doi: 10.1084/jem.189.6.1005
– ident: 177
  doi: 10.1038/nri3071
– ident: 81
  doi: 10.4049/jimmunol.0802221
– ident: 143
  doi: 10.3389/fimmu.2014.00087
– ident: 61
  doi: 10.1089/10430349850019445
– ident: 82
  doi: 10.4049/jimmunol.177.1.566
– ident: 127
  doi: 10.1016/S1074-7613(00)80186-7
– ident: 26
  doi: 10.1002/ana.22054
– ident: 111
  doi: 10.1126/science.3131876
– ident: 13
  doi: 10.1002/eji.1830250723
– ident: 32
  doi: 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A
– ident: 86
  doi: 10.1002/ana.21652
– ident: 24
  doi: 10.1016/0165-5728(93)90240-Y
– volume: 154
  start-page: 4309
  issue: 9
  year: 1995
  ident: 170
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.154.9.4309
– ident: 176
  doi: 10.1126/science.1227901
– ident: 42
  doi: 10.1212/WNL.37.7.1097
– ident: 125
  doi: 10.4049/jimmunol.174.10.5950
– ident: 72
  doi: 10.1016/j.cellimm.2005.11.002
– ident: 33
  doi: 10.1016/0165-5728(94)00139-F
– volume: 20
  start-page: 5283
  issue: 14
  year: 2000
  ident: 152
  publication-title: Journal of Neuroscience
  doi: 10.1523/JNEUROSCI.20-14-05283.2000
– ident: 21
  doi: 10.1007/s11910-009-0060-3
– ident: 11
  doi: 10.1038/nri2190
– ident: 198
  doi: 10.1073/pnas.92.26.12041
– ident: 126
  doi: 10.1038/nm.3485
– ident: 31
  doi: 10.1080/08916930400001859
– ident: 108
  doi: 10.1038/nm1564
– volume: 11
  start-page: 677
  issue: 4
  year: 2000
  ident: 68
  publication-title: European Cytokine Network
– ident: 70
  doi: 10.1016/S0165-5728(98)00053-8
– ident: 181
  doi: 10.1371/journal.pone.0054841
– ident: 106
  doi: 10.1038/nature03725
– ident: 189
  doi: 10.1002/glia.22616
– volume: 171
  start-page: 1706
  issue: 7
  year: 2013
  ident: 95
  publication-title: British Journal of Pharmacology
– ident: 122
  doi: 10.1371/journal.pone.0017988
– ident: 27
  doi: 10.1016/j.bbi.2007.11.010
– ident: 99
  doi: 10.1084/jem.192.3.393
– ident: 60
  doi: 10.1038/sj.gt.3301357
– ident: 184
  doi: 10.1523/JNEUROSCI.1137-14
– ident: 15
  doi: 10.1073/pnas.97.7.3412
– ident: 199
  doi: 10.4061/2011/164608
– ident: 147
  doi: 10.1084/jem.186.10.1677
– ident: 17
  doi: 10.1093/intimm/13.3.257
– ident: 120
  doi: 10.1371/journal.pone.0021386
– ident: 166
  doi: 10.1007/s00401-014-1267-1
– ident: 100
  doi: 10.1056/NEJMoa1100648
– ident: 132
  doi: 10.1038/82717
– ident: 131
  doi: 10.1016/j.jneuroim.2012.02.015
– volume: 28
  start-page: 1681
  issue: 5
  year: 1998
  ident: 145
  publication-title: European Journal of Immunology
  doi: 10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T
– ident: 18
  doi: 10.1038/nrn3275
– ident: 79
  doi: 10.1084/jem.20041257
– ident: 182
  doi: 10.1111/j.1365-2249.2005.02934.x
– ident: 85
  doi: 10.1093/brain/awp289
– ident: 129
  doi: 10.1016/S0165-5728(99)00133-2
– ident: 5
  doi: 10.1056/NEJM200009283431307
– ident: 194
  doi: 10.1002/glia.21088
– ident: 62
  doi: 10.3390/ijms15021700
– ident: 44
  doi: 10.1016/j.bbi.2010.01.014
– ident: 89
  doi: 10.1126/science.256.5060.1213
– ident: 8
  doi: 10.1212/WNL.46.4.907
– ident: 136
  doi: 10.1038/ni833
– ident: 151
  doi: 10.1371/journal.pone.0060862
– ident: 204
  doi: 10.1523/JNEUROSCI.3411-10.2010
– volume: 71
  start-page: ii16
  issue: 2
  year: 2001
  ident: 6
  publication-title: Neurology in Practice
– ident: 9
  doi: 10.1001/archneur.56.9.1079
– ident: 36
  doi: 10.1038/nm0198-078
– ident: 22
  doi: 10.1002/eji.1830110307
– ident: 57
  doi: 10.1093/intimm/9.5.799
– ident: 209
  doi: 10.1016/j.nbd.2011.05.021
– ident: 119
  doi: 10.1084/jem.184.5.1609
– ident: 97
  doi: 10.4049/jimmunol.1300822
– ident: 77
  doi: 10.1002/eji.201040489
– ident: 154
  doi: 10.1016/S0165-5728(98)00014-9
– ident: 87
  doi: 10.1038/nm1651
– ident: 83
  doi: 10.1172/JCI35997
– ident: 45
  doi: 10.1111/j.1365-2567.2010.03261.x
– ident: 104
  doi: 10.1172/JCI63681
– ident: 38
  doi: 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T
– volume: 161
  start-page: 3299
  issue: 7
  year: 1998
  ident: 64
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.161.7.3299
– ident: 164
  doi: 10.1002/jnr.20488
– ident: 191
  doi: 10.1016/j.bbi.2011.05.003
– ident: 56
  doi: 10.4049/jimmunol.175.11.7202
– ident: 7
  doi: 10.1212/WNL.0000000000000560
– ident: 102
  doi: 10.1056/NEJMoa0802670
– reference: 8820272 - Immunol Today. 1996 Mar;17(3):138-46
– reference: 21197107 - Autoimmune Dis. 2010 Dec 15;2011:164608
– reference: 15931287 - Clin Med Res. 2003 Jan;1(1):57-60
– reference: 11006371 - N Engl J Med. 2000 Sep 28;343(13):938-52
– reference: 11222494 - Int Immunol. 2001 Mar;13(3):257-64
– reference: 24463292 - Int J Mol Sci. 2014 Jan 23;15(2):1700-18
– reference: 21992960 - Clin Immunol. 2011 Dec;141(3):348-56
– reference: 16116190 - J Immunol. 2005 Sep 1;175(5):3025-32
– reference: 18802481 - J Clin Invest. 2008 Oct;118(10):3420-30
– reference: 18033300 - Nature. 2007 Nov 22;450(7169):566-9
– reference: 22035960 - J Neuroimmunol. 2011 Dec 15;240-241:97-103
– reference: 3110648 - Neurology. 1987 Jul;37(7):1097-102
– reference: 10852536 - Ann Neurol. 2000 Jun;47(6):707-17
– reference: 19339255 - Brain. 2009 May;132(Pt 5):1175-89
– reference: 20641064 - Ann Neurol. 2010 Sep;68(3):369-83
– reference: 10449104 - Neurology. 1999 Aug 11;53(3):457-65
– reference: 7621871 - Eur J Immunol. 1995 Jul;25(7):1951-9
– reference: 15657292 - J Exp Med. 2005 Jan 17;201(2):233-40
– reference: 19234157 - J Immunol. 2009 Mar 1;182(5):2628-40
– reference: 22837037 - Nat Neurosci. 2012 Jul 26;15(8):1074-7
– reference: 24531377 - Nat Med. 2014 Mar;20(3):272-82
– reference: 9756642 - Cell Immunol. 1998 Sep 15;188(2):118-24
– reference: 10488808 - Arch Neurol. 1999 Sep;56(9):1079-84
– reference: 24871874 - Neurology. 2014 Jul 15;83(3):278-86
– reference: 15885305 - J Neuroimmunol. 2005 Jun;163(1-2):24-30
– reference: 16520032 - Eur J Cancer. 2006 Apr;42(6):717-27
– reference: 17712344 - Nat Immunol. 2007 Sep;8(9):913-9
– reference: 21359213 - PLoS One. 2011 Feb 16;6(2):e17103
– reference: 23916894 - Brain Behav Immun. 2013 Nov;34:98-107
– reference: 16386239 - Cell Immunol. 2005 Oct;237(2):123-30
– reference: 24372081 - Br J Pharmacol. 2014 Apr;171(7):1706-21
– reference: 9603475 - Eur J Immunol. 1998 May;28(5):1681-8
– reference: 20813772 - Mult Scler. 2011 Jan;17 (1):2-15
– reference: 21425186 - Ann Neurol. 2011 Apr;69(4):721-34
– reference: 9888990 - Mol Cell Neurosci. 1998 Dec;12(6):376-89
– reference: 7860709 - J Neuroimmunol. 1995 Feb;56(2):135-41
– reference: 12849456 - Lancet Neurol. 2002 Aug;1(4):232-41
– reference: 23995070 - Nat Neurosci. 2013 Oct;16(10):1401-8
– reference: 9427610 - Nat Med. 1998 Jan;4(1):78-83
– reference: 15812814 - Glia. 2005 Aug 15;51(3):235-40
– reference: 11724442 - Mult Scler. 2001 Oct;7(5):277-84
– reference: 9151795 - J Clin Invest. 1997 May 1;99(9):2225-31
– reference: 9759845 - J Immunol. 1998 Oct 1;161(7):3299-306
– reference: 15959904 - J Neurosci Res. 2005 Aug 1;81(3):374-89
– reference: 16301612 - J Immunol. 2005 Dec 1;175(11):7103-7
– reference: 16675847 - FASEB J. 2006 May;20(7):896-905
– reference: 23221338 - J Clin Invest. 2013 Jan;123(1):247-60
– reference: 21652010 - J Neuroimmunol. 2011 Jul;236(1-2):111-7
– reference: 21731726 - PLoS One. 2011;6(6):e21386
– reference: 17923502 - J Exp Med. 2007 Oct 29;204(11):2591-602
– reference: 23871638 - J Autoimmun. 2013 Sep;45:68-79
– reference: 17874423 - Eur J Immunol. 2007 Nov;37(11):3021-9
– reference: 8102159 - J Immunol. 1993 Aug 15;151(4):2132-41
– reference: 14983026 - Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2428-33
– reference: 23401502 - Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3543-8
– reference: 8920851 - J Exp Med. 1996 Nov 1;184(5):1609-17
– reference: 15621573 - Autoimmunity. 2004 Sep-Nov;37(6-7):465-71
– reference: 20687208 - Ann Neurol. 2010 Oct;68(4):465-76
– reference: 22150037 - N Engl J Med. 2011 Dec 8;365(23):2188-97
– reference: 22079990 - J Immunol. 2012 Jan 1;188(1):29-36
– reference: 20737479 - Glia. 2010 Nov 15;58(15):1847-57
– reference: 21373721 - Mol Med. 2011 May-Jun;17(5-6):442-7
– reference: 20138983 - Brain Behav Immun. 2010 May;24(4):641-51
– reference: 19870180 - J Exp Med. 1933 Jun 30;58(1):39-53
– reference: 20540117 - Eur J Immunol. 2010 Aug;40(8):2340-8
– reference: 8598493 - J Immunol. 1996 Jan 1;156(1):5-7
– reference: 9590229 - J Immunol. 1998 May 15;160(10):4822-30
– reference: 25056715 - Eur J Immunol. 2014 Oct;44(10):2903-17
– reference: 24920622 - J Neurosci. 2014 Jun 11;34(24):8175-85
– reference: 9182689 - J Exp Med. 1997 Jun 16;185(12):2177-82
– reference: 19050244 - J Immunol. 2008 Dec 15;181(12):8278-87
– reference: 3131876 - Science. 1988 May 27;240(4856):1169-76
– reference: 16237080 - J Immunol. 2005 Nov 1;175(9):5875-84
– reference: 10605010 - J Immunol. 2000 Jan 1;164(1):183-90
– reference: 9663557 - J Neuroimmunol. 1998 Jun 15;86(2):123-33
– reference: 9295034 - Eur J Immunol. 1997 Aug;27(8):1973-81
– reference: 11390514 - J Immunol. 2001 Jun 15;166(12):7579-87
– reference: 9338786 - Nature. 1997 Oct 16;389(6652):737-42
– reference: 19540601 - J Neuroimmunol. 2009 Aug 18;213(1-2):60-8
– reference: 9670859 - J Neuroimmunol. 1998 Jul 1;87(1-2):171-8
– reference: 1538783 - Nature. 1992 Mar 5;356(6364):63-6
– reference: 9352427 - Int J Neurosci. 1997 Aug;90(3-4):187-202
– reference: 9670842 - J Neuroimmunol. 1998 Jul 1;87(1-2):27-32
– reference: 22949039 - Stem Cells. 2012 Dec;30(12):2820-9
– reference: 21046558 - Glia. 2011 Jan;59(1):166-76
– reference: 20483737 - J Immunol. 2010 Jun 15;184(12):7144-53
– reference: 21804537 - Nat Neurosci. 2011 Jul 31;14(9):1142-9
– reference: 10075984 - J Exp Med. 1999 Mar 15;189(6):1005-10
– reference: 18835435 - Brain Behav Immun. 2009 Jan;23(1):92-100
– reference: 18793860 - Cytokine. 2008 Oct;44(1):22-5
– reference: 16301624 - J Immunol. 2005 Dec 1;175(11):7202-8
– reference: 23011975 - Eur J Immunol. 2013 Jan;43(1):115-24
– reference: 17384649 - Nat Med. 2007 Apr;13(4):423-31
– reference: 8976182 - J Exp Med. 1996 Dec 1;184(6):2271-8
– reference: 19890056 - J Immunol. 2009 Dec 1;183(11):7169-77
– reference: 24563023 - Acta Neuropathol. 2014 Aug;128(2):231-46
– reference: 21620951 - Brain Behav Immun. 2011 Nov;25(8):1554-68
– reference: 22948090 - J Neuroimmunol. 2013 Jan 15;254(1-2):165-9
– reference: 9362528 - J Exp Med. 1997 Nov 17;186(10):1677-87
– reference: 21984069 - Nat Rev Immunol. 2011 Oct 10;11(11):738-49
– reference: 7722289 - J Immunol. 1995 May 1;154(9):4309-21
– reference: 10064079 - Eur J Immunol. 1999 Feb;29(2):626-32
– reference: 21248152 - J Leukoc Biol. 2011 Apr;89(4):557-63
– reference: 22605909 - P T. 2012 Mar;37(3):175-84
– reference: 22368274 - J Immunol. 2012 Apr 1;188(7):3188-98
– reference: 23746653 - Am J Pathol. 2013 Aug;183(2):516-25
– reference: 10884312 - J Neurosci. 2000 Jul 15;20(14):5283-91
– reference: 8871615 - J Immunol. 1996 Oct 15;157(8):3223-7
– reference: 3139757 - J Immunol. 1988 Oct 1;141(7):2407-12
– reference: 21437244 - PLoS One. 2011 Mar 18;6(3):e17988
– reference: 19234160 - J Immunol. 2009 Mar 1;182(5):2665-71
– reference: 21516112 - Nat Immunol. 2011 Jun;12(6):560-7
– reference: 17828272 - Nat Med. 2007 Oct;13(10):1173-5
– reference: 7479938 - Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11066-70
– reference: 19933767 - Brain. 2009 Dec;132(Pt 12):3329-41
– reference: 10755620 - Immunity. 2000 Mar;12(3):335-45
– reference: 20406305 - Immunology. 2010 Aug;130(4):572-88
– reference: 22768101 - PLoS One. 2012;7(6):e39625
– reference: 19364933 - Arch Neurol. 2009 Apr;66(4):483-9
– reference: 18538310 - Brain Res. 2008 Jul 11;1219:116-26
– reference: 16585503 - Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6
– reference: 7689581 - J Neuroimmunol. 1993 Jul;46(1-2):113-21
– reference: 3126227 - J Immunol. 1988 Mar 1;140(5):1506-10
– reference: 6165588 - Eur J Immunol. 1981 Mar;11(3):195-9
– reference: 15964696 - Neuroscience. 2005;134(1):199-205
– reference: 24123686 - J Immunol. 2013 Nov 15;191(10):4960-8
– reference: 14976054 - Blood. 2004 Jun 1;103(11):4222-31
– reference: 19759299 - J Neurosci. 2009 Sep 16;29(37):11511-22
– reference: 20951792 - Brain Behav Immun. 2011 Jul;25(5):932-7
– reference: 9565643 - J Exp Med. 1998 May 4;187(9):1517-28
– reference: 8780061 - Neurology. 1996 Apr;46(4):907-11
– reference: 19075395 - J Clin Invest. 2009 Jan;119(1):61-9
– reference: 24269558 - Am J Pathol. 2014 Feb;184(2):507-19
– reference: 12610626 - Nature. 2003 Feb 13;421(6924):744-8
– reference: 22547654 - J Exp Med. 2012 May 7;209(5):1001-10
– reference: 20035511 - Ann Neurol. 2009 Dec;66(6):739-53
– reference: 23890271 - J Neuroinflammation. 2013 Jul 27;10:94
– reference: 19664372 - Curr Neurol Neurosci Rep. 2009 Sep;9(5):411-7
– reference: 21653838 - J Neurosci. 2011 Jun 8;31(23):8329-41
– reference: 20953201 - Nat Immunol. 2010 Dec;11(12):1093-101
– reference: 23418431 - PLoS One. 2013;8(2):e54841
– reference: 22848713 - PLoS One. 2012;7(7):e42088
– reference: 16921173 - Brain. 2006 Dec;129(Pt 12):3165-72
– reference: 17617587 - J Immunol. 2007 Jul 15;179(2):958-66
– reference: 1375398 - Science. 1992 May 22;256(5060):1213-5
– reference: 20303295 - Immunity. 2010 Mar 26;32(3):414-25
– reference: 23664330 - J Neuroimmunol. 2013 Jul 15;260(1-2):17-27
– reference: 19305396 - Nat Immunol. 2009 May;10(5):514-23
– reference: 22714021 - Nat Rev Neurosci. 2012 Jun 20;13(7):507-14
– reference: 21212154 - Int Immunol. 2011 Feb;23(2):139-48
– reference: 7679952 - Cell. 1993 Feb 26;72(4):551-60
– reference: 24572363 - Nature. 2014 Mar 20;507(7492):366-70
– reference: 24639677 - Front Immunol. 2014 Mar 07;5:87
– reference: 11402297 - Gene Ther. 2001 Jan;8(1):13-9
– reference: 11701779 - J Neurol Neurosurg Psychiatry. 2001 Dec;71 Suppl 2:ii16-9
– reference: 11535634 - J Exp Med. 2001 Sep 3;194(5):669-76
– reference: 10580814 - J Neuroimmunol. 1999 Nov 1;101(1):61-7
– reference: 23577171 - PLoS One. 2013;8(4):e60862
– reference: 24111507 - Clin Exp Immunol. 2014 Jan;175(1):41-8
– reference: 9184926 - Int Immunol. 1997 May;9(5):799-803
– reference: 15067033 - J Exp Med. 2004 Apr 5;199(7):971-9
– reference: 23307732 - Science. 2013 Jan 11;339(6116):156-61
– reference: 1589800 - Science. 1992 May 22;256(5060):1210-3
– reference: 12244307 - Nat Immunol. 2002 Oct;3(10):944-50
– reference: 24481666 - Glia. 2014 May;62(5):680-91
– reference: 17634104 - BMC Immunol. 2007 Jul 16;8:10
– reference: 21131957 - Nat Med. 2011 Jan;17(1):64-70
– reference: 22531276 - J Neuroimmunol. 2012 Jun 15;247(1-2):86-94
– reference: 15931212 - Nature. 2005 Jun 2;435(7042):598-604
– reference: 18946064 - N Engl J Med. 2008 Oct 23;359(17):1786-801
– reference: 16297160 - Clin Exp Immunol. 2005 Dec;142(3):481-9
– reference: 16206232 - Eur J Immunol. 2005 Nov;35(11):3343-52
– reference: 7689582 - J Neuroimmunol. 1993 Jul;46(1-2):123-8
– reference: 11956029 - Eur Cytokine Netw. 2002 Jan-Mar;13(1):110-4
– reference: 22073221 - PLoS One. 2011;6(11):e26921
– reference: 16785554 - J Immunol. 2006 Jul 1;177(1):566-73
– reference: 21679768 - Neurobiol Dis. 2011 Sep;43(3):678-89
– reference: 9436789 - Glia. 1998 Jan;22(1):72-85
– reference: 17917672 - Nat Rev Immunol. 2007 Nov;7(11):904-12
– reference: 22443691 - Autoimmunity. 2012 Aug;45(5):388-99
– reference: 23596391 - Front Cell Neurosci. 2013 Apr 08;7:34
– reference: 10934227 - J Exp Med. 2000 Aug 7;192(3):393-404
– reference: 1732276 - J Neuroimmunol. 1992 Feb;36(2-3):105-15
– reference: 24021808 - Neurosci Lett. 2013 Oct 25;554:146-50
– reference: 8691133 - J Exp Med. 1996 Jul 1;184(1):19-29
– reference: 22458983 - J Neuroimmunol. 2012 May 15;246(1-2):85-95
– reference: 11125313 - Eur Cytokine Netw. 2000 Dec;11(4):677-81
– reference: 22469520 - Cell Transplant. 2012;21(9):1883-97
– reference: 9853527 - Hum Gene Ther. 1998 Nov 20;9(17):2605-17
– reference: 15593305 - Eur J Immunol. 2005 Jan;35(1):76-85
– reference: 24652058 - Acta Neuropathol. 2014 Sep;128(3):319-31
– reference: 18354171 - J Immunol. 2008 Apr 1;180(7):4495-506
– reference: 11101868 - Nat Immunol. 2000 Dec;1(6):475-82
– reference: 9348316 - J Exp Med. 1997 Nov 3;186(9):1585-90
– reference: 21123584 - J Neurosci. 2010 Dec 1;30(48):16383-90
– reference: 20399501 - Mol Immunol. 2010 Jun;47(10):1890-8
– reference: 19475668 - Ann Neurol. 2009 May;65(5):499-509
– reference: 16802293 - Ann Neurol. 2006 Jul;60(1):12-21
– reference: 16633347 - Nat Med. 2006 May;12(5):518-25
– reference: 10737797 - Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3412-7
– reference: 22928273 - JAAPA. 2012 Aug;25(8):24-9
– reference: 15879087 - J Immunol. 2005 May 15;174(10):5950-8
– reference: 24357067 - Glia. 2014 Mar;62(3):452-67
– reference: 24157130 - J Neuroimmunol. 2013 Dec 15;265(1-2):124-7
– reference: 18156204 - Am J Pathol. 2008 Jan;172(1):146-55
– reference: 10092079 - Eur J Immunol. 1999 Mar;29(3):774-80
– reference: 8618840 - Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12041-5
– reference: 19636355 - PLoS Med. 2009 Jul;6(7):e1000113
– reference: 18703004 - Lancet Neurol. 2008 Sep;7(9):796-804
– reference: 18207698 - Brain Behav Immun. 2008 May;22(4):421-30
SSID ssj0000502783
Score 2.237739
SecondaryResourceType review_article
Snippet Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterised by widespread areas of focal demyelination. Its aetiology...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
hindawi
emarefa
airiti
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 56
SubjectTerms Analysis
Antigens
Autoimmune diseases
Cytokines
Development and progression
Encephalomyelitis
Genetic aspects
Immune system
Lymphocytes
Multiple sclerosis
Nervous system
Neurodegeneration
Paralysis
Pathogenesis
Physiological aspects
Proteins
Review
Tumor necrosis factor-TNF
SummonAdditionalLinks – databaseName: ProQuest Publicly Available Content Database
  dbid: PIMPY
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdb2sJg7PsjW7ZprDAomNiyJMtPI4R060NLYBt0T0aRZGJI7a5ONvbf785W3HiUPu0tiS72STrdh6T7HSGHUps8T0IbJKHmAVdWBjqULLCxNWoRCrHgi6bYRHJ2ps7P07lPj679tcqtTmwUdYv2jPe2QQmPbWVwx3yMcQjYTiX5p8ufAdaQwrNWX1DjLtlD4C01IHvzk9P5j27PJRR4zoaHzixMw4BJwX3KHljVMZhCPmZKMExt2tcFggr1rNWBu9DwQXfa-2CJcfPv4ibv9N9LljtW6_jh_-3vI_LAe6900orbY3LHlU_I_Xbrj7YZTU9JDaJHEfVqW0uLVjk9wTwUR3Vp6ecVyDydutWKYhRc06Kks51CA3SyWVdFSz_DpMqlXlUXfxxe1KubJ5z6W5D0K3ABA1fUz8j349m36ZfA13YItGRqHUAgIyLL8tQYpyK3UNIiMpqUuTK5AbfCSWaY00mkQUVYlzIFgpNbkzvu4kTHz8mgrEr3klDwwGRkTZTylIN1DdXC2RzCNFDcOnaRHJJpO5mZX551Noe5FgidBtotw3mPWNb9BE5x_4uQWcKG5GgrCZnx8OlYxWOVNWGUEM1zslZ-huSwI75sUUNuJnvhRWqHikuRAs_vUMSyNhm200LZhIOFQezIaEg-NhSoh4APo306BYwJInr1KEc9StAfptf8wYvx7ayOtmJ6PYzXUjkk77tmfD7e3CtdtamzSDKGbrNIoLftiujew0SccJnCv5PeWukIEPu831IWywYDHdiP4ki8up2t1-Qe9qHdMhuRwfpq496QffML5PXqrVcPfwFosWyQ
  priority: 102
  providerName: ProQuest
Title The Contribution of Immune and Glial Cell Types in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
URI https://www.airitilibrary.com/Article/Detail/P20151210011-201412-201512100013-201512100013-56-72
https://search.emarefa.net/detail/BIM-1046596
https://dx.doi.org/10.1155/2014/285245
https://www.ncbi.nlm.nih.gov/pubmed/25374694
https://www.proquest.com/docview/2407658864
https://www.proquest.com/docview/1622061557
https://pubmed.ncbi.nlm.nih.gov/PMC4211315
Volume 2014
WOSCitedRecordID wos000215745600007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: ProQuest - Health & Medical Complete保健、医学与药学数据库
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 20240131
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: 7X7
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 20240131
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: BENPR
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 20240131
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: PIMPY
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: 24P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1db9Mw0KKDSUgI8b1CKUZMQkKKiB3bcR5L1bE9rKoGSOUpcm1HjdSl09KC-PfcJWloxoR4aZv64lx85_uw786EHCtjsywOXRCHRgRCOxWYUPHARc7qRSjlQiyqwybi6VTP58msCZAt_97CB20H7jkTH7mWXMge6WmJvHtxOm9XUkKJu2e4lczDJAy4kqJJxLtxNygZk2OpoI4OOvSXBn6YViYfLtEb_pnfZnPeDJ3c00Unj8jDxoiko5rqj8kdXzwhD-oVOFonFj0lJXAAxeJTuyOt6DqjZ5gO4qkpHP28AtajY79aUXRGS5oXdLJX75-Otpt1XsNPMLdxaVbry18e4-XKqofzJhiRfgEs4E3z8hn5djL5Oj4NmiMWAqO43gTgT0jmeJZY6zXzC60cFihTKtM2s6DdveKWexMzAzPV-YRroF_mbOaFj2ITPScHxbrwR4SCIaSYsywRiQAlF-qFdxl4SyA_TeSZ6pNxPfppM0vKdAbEkVjBDIRMioRiPG3_Atu0eyFVGvM--bAjXWqbKuZ4mMYqrbwZKat-0prgfXLcAl_VxTtuB3vR8MAelFAyAZzfIE-kdU5qKwzSkQBBjyUcWZ-8ryBQHAAe1jRZDTAmWFirAznoQMI0tp3mdw3f_RvVwY4n_wwjOuVgSGol-uRt24z9YwBd4dfbMmWKc7ReZQxvW7Nw-xwuo1ioBO6OO8zdAmAJ8m5LkS-rUuSAPouYfPlfyL8i9_GqXsAakIPN9da_JvfsD2Db6yHpxfO4-tRDcvfTZDq7gO_Z2fns-7Ca8L8BT8FDYQ
linkProvider Hindawi Publishing
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3batswVHRdywZj90u2bNVYx2BgYiuWbD-MEbJ0DW1DYS3kTVMkmRhSu6ublf7UvnHn-NZ4lL71YW9JdCIfyecqnQsh20LpOA5c4wSu8h0_NMJRrmCO6RsdzlzOZ_6saDYRTCbhdBodrpE_dS4MhlXWMrEQ1CbTeEbeQ88DtGUo_K-nvxzsGoW3q3ULjZIs9uzlBbhs-ZfxN3i_HxnbGR0Nd52qq4CjBAvPHTChuWdYHGltQ8_OQmGwJpcQcahjDQrNCqaZVYGngDiNjVgIKMdGx9a3_UD1Yd475C7I8QBDyIJp0JzpuBzv8fBSm7mR6zDB_SolELR2D1St32MhZ5g6taESLFrU0oab9kTBB9Voh805-uUXyXXW779BnCtacefR_7afj8nDyv6mg5JhnpA1mz4lD8rDS1rmZD0jOTAPxbpddTcwmsV0jJk0lqrU0O8L4Fo6tIsFRT8-p0lKRyutEuhgeZ4lJfwI00LnapGdXFoMNcyLGQ6qOE76A7CAV5Pkz8nxraz7BVlPs9S-IhRsSOEZ7UV-5ANdueHMmhgcTVA9qm890SHDklxkJWByeQjUxLH4G8hniZTlMdn8BGZ9-wsXMmAd8rmmNamrAvDYh2QhC0eQ82IeWVJoh2w3wKdl3ZPrwV5WRLsC5QseAc5bSMSyTOdt5Kgc-KAjsfql1yGfCgiUpICHVlVCCOwJ1iRrQXZbkCABdWv4Q8UoN6ParRnhahuvuKBD3jfDOD_GHqY2W-bSE4yh4c8DWG3Jc81zGO8Hvojg30GLGxsArN7eHkmTeVHFHdD3-h5_fTNaW-Te7tHBvtwfT_bekPu4nvIAsEvWz8-W9i3Z0L-Bds_eFaKIkp-3zat_AXuBvZc
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3bbtMw1BpjQ0iI-6VQmBFDSEhREye2kweEqm6FalBVAqS-Gddx1EhdMpaWab_G13FOkmYNmva2B97a-tQ5ds7VPhdC9oU2SSLd2JGuDpwgjIWjXcGc2I9NOHM5nwWzstmEHI_D6TSabJE_61wYDKtcy8RSUMe5wTPyHnoeoC1DEfSSOixicjD8ePLLwQ5SeNO6bqdRkciRPT8D9634MDqAd_2WseHh98Fnp-4w4GjBwqUD5jT3YpZExtjQs7NQxFifS4gkNIkB5WYFM8xq6Wkg1NhGLAT0k9gkNrC-1D7Me4PclL4vsW2EnMrmfMfleKeHF9zMjVyHCR7U6YGgwXugdoMeCznDNKodnWIBo5Zm3LXHGj7oRlPsztFHP0svs4T_Dejc0JDDe__z3t4nd2u7nPYrRnpAtmz2kNypDjVplav1iBTAVBTrea27hNE8oSPMsLFUZzH9tABupgO7WFD07wuaZvRwo4UC7a-WeVrBH2K66Fwv8uNziyGIRTnD1zq-k34DLOA1pcVj8uNa1v2EbGd5Zp8RCral8GLjRUEUgN3ghjMbJ-CAgkrSvvVEhwwq0lG14CnUBCiLY1E4kNsKqcxjqvkJzP32Fy6UZB3yfk13ytSF4bE_yUKVDiLn5TyqotYO2W-AT6p6KJeDPa0JeAMqEDwCnPeQoFWV5tvIV9UPQHdiVUyvQ96VEChhAQ-j60QR2BOsVdaC7LYgQTKa1vCbmmmuRrW7ZoqLbbzgiA553Qzj_BiTmNl8VShPMIYOAZew2or_mucw7stARPBv2eLMBgCrurdHsnReVncH9D3f48-vRmuP3AIWVV9G46MX5DYupzoX7JLt5enKviQ75jeQ7umrUipR8vO6WfUv7-LGSw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Contribution+of+Immune+and+Glial+Cell+Types+in+Experimental+Autoimmune+Encephalomyelitis+and+Multiple+Sclerosis&rft.jtitle=Multiple+sclerosis+international&rft.au=Duffy%2C+Samuel+S.&rft.au=Lees%2C+Justin+G.&rft.au=Moalem-Taylor%2C+Gila&rft.date=2014-01-01&rft.issn=2090-2654&rft.eissn=2090-2662&rft.volume=2014&rft.spage=1&rft.epage=17&rft_id=info:doi/10.1155%2F2014%2F285245&rft.externalDBID=n%2Fa&rft.externalDocID=10_1155_2014_285245
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fwww.airitilibrary.com%2Fjnltitledo%2FP20151210011-c.jpg